HE
MCID: EHR002
MIFTS: 44

Ehrlichiosis (HE)

Categories: Infectious diseases, Rare diseases

Aliases & Classifications for Ehrlichiosis

MalaCards integrated aliases for Ehrlichiosis:

Name: Ehrlichiosis 12 75 53 59 55 44 15 72
Human Ehrlichiosis 12 53 72
Hey 17
He 53

Characteristics:

Orphanet epidemiological data:

59
ehrlichiosis
Prevalence: 1-9/1000000 (United States); Age of onset: All ages;

Classifications:

Orphanet: 59  
Rare infectious diseases


External Ids:

Disease Ontology 12 DOID:10242
ICD9CM 35 082.4 082.40
MeSH 44 D016873
SNOMED-CT 68 77361002
ICD10 33 A77.4 A77.40
MESH via Orphanet 45 D016873
ICD10 via Orphanet 34 A48.8
UMLS via Orphanet 73 C0085399
Orphanet 59 ORPHA1902
UMLS 72 C0085399 C0343771

Summaries for Ehrlichiosis

Disease Ontology : 12 A primary bacterial infectious disease that results in infection located in leukocyte, has material basis in Ehrlichia chaffeensis or Anaplasma phagocytophilum, which are transmitted by lone start stick and transmitted by black-legged tick respectively. The infection has symptom headache, has symptom muscle aches, has symptom fatigue and has symptom rash.

MalaCards based summary : Ehrlichiosis, also known as human ehrlichiosis, is related to human granulocytic anaplasmosis and malaria. An important gene associated with Ehrlichiosis is FUT7 (Fucosyltransferase 7), and among its related pathways/superpathways are Toxoplasmosis and Cell adhesion molecules (CAMs). The drugs Protective Agents and Insect Repellents have been mentioned in the context of this disorder. Affiliated tissues include monocytes, testes and neutrophil, and related phenotypes are Mildly decreased CFP-tsO45G cell surface transport and cardiovascular system

Wikipedia : 75 Ehrlichiosis is a tick-borne bacterial infection, caused by bacteria of the family Anaplasmataceae,... more...

Related Diseases for Ehrlichiosis

Diseases related to Ehrlichiosis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 216, show less)
# Related Disease Score Top Affiliating Genes
1 human granulocytic anaplasmosis 32.0 TFRC SELPLG HSPD1 FUT7 CYBB ANK1
2 malaria 28.9 TFRC SELP CD40LG CASP3
3 human monocytic ehrlichiosis 12.8
4 sennetsu fever 12.0
5 tick infestation 11.6
6 hairy ears, y-linked 11.4
7 lyme disease 10.8
8 thrombocytopenia 10.8
9 neutropenia 10.8
10 pancytopenia 10.6
11 babesiosis 10.6
12 exanthem 10.5
13 spotted fever 10.5
14 rocky mountain spotted fever 10.4
15 lymphopenia 10.4
16 helix syndrome 10.4
17 headache 10.4
18 rickettsial disease 10.4
19 encephalitis 10.3
20 tick-borne encephalitis 10.3
21 hemophagocytic lymphohistiocytosis 10.3
22 diarrhea 10.3
23 posttransplant acute limbic encephalitis 10.3
24 retinitis pigmentosa 44 10.2
25 purpura 10.2
26 vasculitis 10.2
27 acute respiratory distress syndrome 10.2
28 splenomegaly 10.2
29 hypercholesterolemia, familial, 1 10.2
30 hypertriglyceridemia, familial 10.2
31 ovarian cancer 10.2
32 intestine carcinoma in situ 10.2 SELPLG CD40LG
33 colon carcinoma in situ 10.2 SELPLG CD40LG
34 ataxia and polyneuropathy, adult-onset 10.2
35 respiratory failure 10.2
36 toxic shock syndrome 10.2
37 severe combined immunodeficiency 10.2
38 secondary hemophagocytic lymphohistiocytosis 10.2
39 primary thrombocytopenia 10.2 SELP CD40LG
40 pustulosis palmaris et plantaris 10.2 SELPLG CD40LG
41 thrombotic thrombocytopenic purpura 10.1
42 acute kidney failure 10.1
43 myocarditis 10.1
44 47,xyy 10.1
45 autism 10.1
46 ovary adenocarcinoma 10.1
47 rare disease in surgical orthopedic 10.1
48 legg-calve-perthes disease 10.1 SELP CD40LG
49 q fever 10.1
50 visual epilepsy 10.1
51 nephrotic syndrome 10.1
52 uveitis 10.1
53 glomerulonephritis 10.1
54 meningitis 10.1
55 cytokine deficiency 10.1
56 seizure disorder 10.1
57 anemia, sideroblastic, 1 10.1 TFRC ACO1
58 retinal detachment 10.0
59 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
60 yemenite deaf-blind hypopigmentation syndrome 10.0
61 retinitis pigmentosa 30 10.0
62 hydrops, lactic acidosis, and sideroblastic anemia 10.0
63 deficiency anemia 10.0
64 second-degree atrioventricular block 10.0
65 bacterial infectious disease 10.0
66 meningoencephalitis 10.0
67 lipoid nephrosis 10.0
68 bartonellosis 10.0
69 adult respiratory distress syndrome 10.0
70 panuveitis 10.0
71 optic neuritis 10.0
72 cholestasis 10.0
73 neuritis 10.0
74 tularemia 10.0
75 bilirubin metabolic disorder 10.0
76 syphilis 10.0
77 conjunctivitis 10.0
78 arteries, anomalies of 10.0
79 blood group--private systems 10.0
80 colorectal cancer 10.0
81 alagille syndrome 1 10.0
82 esophageal cancer 10.0
83 laryngomalacia 10.0
84 papillomatosis, confluent and reticulated 10.0
85 retinoblastoma 10.0
86 rheumatoid arthritis 10.0
87 neuroblastoma 1 10.0
88 pancreatic cancer 10.0
89 anxiety 10.0
90 mycobacterium tuberculosis 1 10.0
91 gastric cancer 10.0
92 immunodeficiency, common variable, 10 10.0
93 chorea, childhood-onset, with psychomotor retardation 10.0
94 hyperlipoproteinemia, type iii 10.0
95 scoliosis 10.0
96 mastoiditis 10.0
97 bone resorption disease 10.0
98 subdural empyema 10.0
99 familial hyperlipidemia 10.0
100 coronary artery anomaly 10.0
101 choreatic disease 10.0
102 brain cancer 10.0
103 basal cell carcinoma 10.0
104 hemangioma 10.0
105 adenocarcinoma 10.0
106 testicular cancer 10.0
107 pleural empyema 10.0
108 familial retinoblastoma 10.0
109 aortic valve insufficiency 10.0
110 acquired immunodeficiency syndrome 10.0
111 hypertrophic cardiomyopathy 10.0
112 ovarian epithelial cancer 10.0
113 hypotonia 10.0
114 idiopathic neutropenia 9.9 CD40LG CASP3
115 cryoglobulinemia, familial mixed 9.8
116 leukemia, acute monocytic 9.8
117 neutrophil migration 9.8
118 polykaryocytosis inducer 9.8
119 enterocolitis 9.8
120 immune deficiency disease 9.8
121 ocular motor apraxia 9.8
122 autoimmune lymphoproliferative syndrome 9.8
123 kala-azar 1 9.8
124 granulomatosis with polyangiitis 9.8
125 retinitis pigmentosa 29 9.8
126 inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 9.8
127 analbuminemia 9.8
128 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.8
129 thrombocytopenia 5 9.8
130 mulchandani-bhoj-conlin syndrome 9.8
131 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.8
132 pulmonary hypertension 9.8
133 acute diarrhea 9.8
134 epidemic typhus 9.8
135 atrioventricular block 9.8
136 lymphoma 9.8
137 bone disease 9.8
138 sensorineural hearing loss 9.8
139 trypanosomiasis 9.8
140 endocarditis 9.8
141 interstitial nephritis 9.8
142 mastitis 9.8
143 qualitative platelet defect 9.8
144 orbital cellulitis 9.8
145 disseminated intravascular coagulation 9.8
146 cat-scratch disease 9.8
147 tick paralysis 9.8
148 pulmonary edema 9.8
149 cryptococcosis 9.8
150 chagas disease 9.8
151 aseptic meningitis 9.8
152 dysentery 9.8
153 leukemia 9.8
154 bell's palsy 9.8
155 posterior uveitis 9.8
156 acute leukemia 9.8
157 blastomycosis 9.8
158 relapsing fever 9.8
159 coccidioidomycosis 9.8
160 scleritis 9.8
161 polyneuropathy 9.8
162 facial paralysis 9.8
163 hypothyroidism 9.8
164 urticaria 9.8
165 angioedema 9.8
166 lymphadenitis 9.8
167 histoplasmosis 9.8
168 hepatitis c 9.8
169 cholecystitis 9.8
170 leptospirosis 9.8
171 gastroenteritis 9.8
172 iron metabolism disease 9.8
173 orchitis 9.8
174 papilloma 9.8
175 acalculous cholecystitis 9.8
176 cryoglobulinemia 9.8
177 membranoproliferative glomerulonephritis 9.8
178 histiocytosis 9.8
179 cellulitis 9.8
180 mastocytosis 9.8
181 lactic acidosis 9.8
182 plexopathy 9.8
183 cranial nerve palsy 9.8
184 pyoderma 9.8
185 hypokalemia 9.8
186 colorado tick fever 9.8
187 demyelinating polyneuropathy 9.8
188 pneumonia 9.8
189 kidney disease 9.8
190 peripheral nervous system disease 9.8
191 hemolytic anemia 9.8
192 congestive heart failure 9.8
193 combined t cell and b cell immunodeficiency 9.8
194 b-cell lymphoma 9.8
195 appendicitis 9.8
196 monocytic leukemia 9.8
197 neuropathy 9.8
198 leishmaniasis 9.8
199 macroglobulinemia 9.8
200 bacterial meningitis 9.8
201 polyarteritis nodosa 9.8
202 toxoplasmosis 9.8
203 hypereosinophilic syndrome 9.8
204 trichorhinophalangeal syndrome 9.8
205 acute monoblastic leukemia 9.8
206 carcinoma showing thymus-like differentiation 9.8
207 granulocytopenia 9.8
208 infectious myocarditis 9.8
209 lymphosarcoma 9.8
210 macrophage activation syndrome 9.8
211 sudden sensorineural hearing loss 9.8
212 encephalopathy 9.8
213 pik3ca-related overgrowth syndrome 9.8
214 glomerular disease 9.8
215 pelvic inflammatory disease 9.8 HSPD1 CD40LG
216 oral lichen planus 9.6 HSPD1 CASP3

Graphical network of the top 20 diseases related to Ehrlichiosis:



Diseases related to Ehrlichiosis

Symptoms & Phenotypes for Ehrlichiosis

GenomeRNAi Phenotypes related to Ehrlichiosis according to GeneCards Suite gene sharing:

26 (showing 1, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Mildly decreased CFP-tsO45G cell surface transport GR00360-A-1 9.23 ACO1 ANK1 CD40LG DNASE1L1 FUT7 HSPD1

MGI Mouse Phenotypes related to Ehrlichiosis:

46 (showing 9, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.06 ANK1 CASP3 CD40LG CYBB FUT7 MMP12
2 hematopoietic system MP:0005397 10.06 ANK1 CASP3 CD40LG CYBB FUT7 MMP12
3 cellular MP:0005384 10.03 CASP3 CD40LG CYBB FUT7 HSPD1 SELP
4 homeostasis/metabolism MP:0005376 10.02 ACO1 ANK1 CASP3 CD40LG CYBB MMP12
5 immune system MP:0005387 9.97 ANK1 CASP3 CD40LG CYBB FUT7 MMP12
6 mortality/aging MP:0010768 9.81 ACO1 ANK1 CASP3 CD40LG CYBB HSPD1
7 integument MP:0010771 9.8 ANK1 CASP3 CD40LG MMP12 SELP SELPLG
8 nervous system MP:0003631 9.56 ANK1 CASP3 CD40LG CYBB HSPD1 MMP12
9 renal/urinary system MP:0005367 9.1 ANK1 CASP3 CD40LG CYBB SELP SELPLG

Drugs & Therapeutics for Ehrlichiosis

Drugs for Ehrlichiosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 3, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Protective Agents
2 Insect Repellents
3 Eucalyptus

Interventional clinical trials:

(showing 2, show less)
# Name Status NCT ID Phase Drugs
1 A School-Based Intervention to Reduce Lyme Disease Unknown status NCT00594997
2 A Single Group Trial to Determine the Complete Protection Time of an Insect Repellent Formulation Containing 30% Citriodiol® (Oil of Lemon Eucalyptus) Against Three Species of Ticks. Recruiting NCT03708120

Search NIH Clinical Center for Ehrlichiosis

Cochrane evidence based reviews: ehrlichiosis

Genetic Tests for Ehrlichiosis

Anatomical Context for Ehrlichiosis

MalaCards organs/tissues related to Ehrlichiosis:

41
Monocytes, Testes, Neutrophil, T Cells, Bone, Bone Marrow, Whole Blood

Publications for Ehrlichiosis

Articles related to Ehrlichiosis:

(showing 1645, show less)
# Title Authors PMID Year
1
Molecular cloning and characterization of the 120-kilodalton protein gene of Ehrlichia canis and application of the recombinant 120-kilodalton protein for serodiagnosis of canine ehrlichiosis. 9 38
10618118 2000
2
Glycosylation of homologous immunodominant proteins of Ehrlichia chaffeensis and Ehrlichia canis. 9 38
10603362 2000
3
Atypical presentation of human ehrlichiosis and anaplasmosis in children in Israel. 38
31140643 2019
4
Acute acalculous cholecystitis as a manifestation of ehrlichiosis. 38
31155368 2019
5
Human ehrlichiosis at a tertiary-care academic medical center: Clinical associations and outcomes of transplant patients and patients with hemophagocytic lymphohistiocytosis. 38
30913447 2019
6
Ehrlichia Isolate from a Minnesota Tick: Characterization and Genetic Transformation. 38
31076433 2019
7
Conventional and Holter Electrocardiographic Assessment of Dogs Infected Naturally With Acute Canine Monocytic Ehrlichiosis. 38
31122685 2019
8
Performance of recombinant chimeric proteins in the serological diagnosis of Trypanosoma cruzi infection in dogs. 38
31242195 2019
9
Seroprevalence of Anaplasma phagocytophilum, Ehrlichia spp. and Borrelia burgdorferi infections in horses: first report from Northern Bulgaria - Short communication. 38
31238733 2019
10
Genetic diversity of Ehrlichia canis in dogs from Turkey inferred by TRP36 sequence analysis and phylogeny. 38
31174695 2019
11
TickPath Layerplex: adaptation of a real-time PCR methodology for the simultaneous detection and molecular surveillance of tick-borne pathogens. 38
31061487 2019
12
First detection of Ehrlichia minasensis in Hyalomma marginatum ticks collected from cattle in Corsica, France. 38
30663864 2019
13
Molecular characterization of Anaplasma and Ehrlichia in ixodid ticks and reservoir hosts from Palestine: a pilot survey. 38
30762295 2019
14
An update on the treatment of canine monocytic ehrlichiosis (Ehrlichia canis). 38
30902188 2019
15
Current Status of Tick-Borne Diseases in South Korea. 38
30328790 2019
16
Anti-Ehrlichia properties of the essential oil of Ageratum conyzoides L. and its interaction with doxycycline. 38
31037564 2019
17
Prevalence of Ehrlichia canis (Rickettsiales: Ehrlichieae) DNA in Tissues From Rhipicephalus sanguineus (Acari: Ixodidae) Ticks in Areas Endemic for Canine Monocytic Ehrlichiosis in Brazil. 38
30566570 2019
18
Evidence of Ehrlichia chaffeensis in Argentina through molecular detection in marsh deer (Blastocerus dichotomus). 38
30619709 2019
19
The rash with maculopapules and fever in adults. 38
30981291 2019
20
A review on the occurrence of companion vector-borne diseases in pet animals in Latin America. 38
30917860 2019
21
Clinicopathological findings in 41 dogs (2008-2018) naturally infected with Ehrlichia ewingii. 38
30604457 2019
22
Molecular identification of Ehrlichia ewingii in a polyarthritic Texas dog. 38
30624796 2019
23
Lyme Neuroborreliosis - The Mystifying Pitfall: "Neuropathology and Current Therapeutics". 38
30919784 2019
24
Isolation and molecular detection of Ehrlichia species from ticks in western, central, and eastern Japan. 38
30501980 2019
25
Seasonality and trends in incidence of human ehrlichiosis in two Missouri ecoregions. 38
30868997 2019
26
Evaluation of heart rate variability and behavior of electrocardiographic parameters in dogs affected by chronic Monocytic Ehrlichiosis. 38
31125348 2019
27
[Molecular-genetic monitoring as the basis of modern epidemiological surveillance of tick-borne infections.] 38
31408595 2019
28
Emerging Roles of Autophagy and Inflammasome in Ehrlichiosis. 38
31134081 2019
29
Sequence Determinants Spanning -10 Motif and Spacer Region Implicated in Unique Ehrlichia chaffeensis Sigma 32-Dependent Promoter Activity of dnaK Gene. 38
31428069 2019
30
Molecular evidence of Ehrlichia canis and Anaplasma platys and the association of infections with hematological responses in naturally infected dogs in Kalasin, Thailand. 38
30936666 2019
31
Ehrlichia spp. infection in domestic cats from Rio de Janeiro State, southeast Brazil. 38
30892460 2019
32
Proteome Analysis Revealed Changes in Protein Expression Patterns Caused by Mutations in Ehrlichia chaffeensis. 38
30937288 2019
33
The relationship between ehrlichiosis and the development of hematologic malignancies. 38
30396493 2018
34
Serological and molecular diagnosis of Ehrlichia canis and associated risk factors in dogs domiciled in western Cuba. 38
31014724 2018
35
Molecular survey and characterization of Theileria annulata and Ehrlichia ruminantium in cattle from Northwest China. 38
29959093 2018
36
Serological Evidence of Borrelia burgdorferi, Anaplasma phagocytophilum and Ehrlichia Spp. Infections in Horses from Southeastern Bulgaria. 38
29969382 2018
37
Ehrlichiosis masquerading as thrombotic thrombocytopenic purpura. 38
30279260 2018
38
Intravascular large B-cell lymphoma: The Great Imitator. 38
30775328 2018
39
Survey and Phylogenetic Analysis of Rodents and Important Rodent-Borne Zoonotic Pathogens in Gedu, Bhutan. 38
30419740 2018
40
Prevalence of canine Babesia and Ehrlichia co-infection and the predictive value of haematology. 38
30326715 2018
41
Ehrlichiosis presenting as severe sepsis and meningoencephalitis in an immunocompetent adult. 38
30425837 2018
42
Tick-borne zoonoses in the Order Rickettsiales and Legionellales in Iran: A systematic review. 38
30204754 2018
43
Two different genogroups of Ehrlichia canis from dogs in Thailand using immunodominant protein genes. 38
29852293 2018
44
Successful Infection of Tick Cell Cultures of Rhipicephalus sanguineus (Tropical Lineage) with Ehrlichia canis. 38
30222504 2018
45
Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplant. 38
29668040 2018
46
Detection of Anaplasmataceae agents and co-infection with other tick-borne protozoa in dogs and Rhipicephalus sanguineus sensu lato ticks. 38
30073430 2018
47
Is it a Drug or a Bug? A Case of Chemotherapy and Immune Modulators Complicating the Diagnosis of Ehrlichiosis. 38
30206467 2018
48
Diagnosing Meat Allergy After Tick Bite Without Delay. 38
29986992 2018
49
Exposure to Ticks and their Pathogens in Northeast Missouri. 38
30228771 2018
50
Protein and DNA synthesis demonstrated in cell-free Ehrlichia chaffeensis organisms in axenic medium. 38
29915240 2018
51
Prevalence of Canine Monocytic Ehrlichiosis in Canine Population Across India. 38
30242799 2018
52
Neospora caninum and Ehrlichia canis co-infection in a dog with meningoencephalitis. 38
29406569 2018
53
Ehrlichia muris in Ixodes cookei Ticks, Northeastern United States, 2016-2017. 38
29774863 2018
54
A new TaqMan method for the reliable diagnosis of Ehrlichia spp. in canine whole blood. 38
29914548 2018
55
Surveillance for and Discovery of Borrelia Species in US Patients Suspected of Tickborne Illness. 38
29272385 2018
56
Molecular detection of Ehrlichia canis in dogs from three districts in Punjab (Pakistan). 38
29851310 2018
57
A lifelong study of a pack Rhodesian ridgeback dogs reveals subclinical and clinical tick-borne Anaplasma phagocytophilum infections with possible reinfection or persistence. 38
29650038 2018
58
Impact of Three Different Mutations in Ehrlichia chaffeensis in Altering the Global Gene Expression Patterns. 38
29670161 2018
59
Ehrlichia chaffeensis TRP75 Interacts with Host Cell Targets Involved in Homeostasis, Cytoskeleton Organization, and Apoptosis Regulation To Promote Infection. 38
29643078 2018
60
The Blacklegged Tick, Ixodes scapularis: An Increasing Public Health Concern. 38
29336985 2018
61
Complete Genome Sequence of Ehrlichia canis Strain YZ-1, Isolated from a Beagle with Fever and Thrombocytopenia. 38
29496840 2018
62
Pathogen transmission in relation to duration of attachment by Ixodes scapularis ticks. 38
29398603 2018
63
Detection and molecular characterisation of Ehrlichia canis in naturally infected dogs in South West Nigeria. 38
29580089 2018
64
Relative Risk for Ehrlichiosis and Lyme Disease Where Vectors for Both Are Sympatric, Southeastern United States. 38
29350157 2018
65
Molecular detection and phylogenetic analysis of Ehrlichia canis in a Philippine dog. 38
28943246 2018
66
QCM-based rapid detection of PCR amplification products of Ehrlichia canis. 38
29291792 2018
67
Ehrlichia and Anaplasma Infections: Serological Evidence and Tick Surveillance in Peninsular Malaysia. 38
29202206 2018
68
Solution NMR structures of oxidized and reduced Ehrlichia chaffeensis thioredoxin: NMR-invisible structure owing to backbone dynamics. 38
29372907 2018
69
Large-scale health disparities associated with Lyme disease and human monocytic ehrlichiosis in the United States, 2007-2013. 38
30261027 2018
70
Development and Clinical Validation of a Multiplex Real-Time Quantitative PCR Assay for Human Infection by Anaplasma phagocytophilum and Ehrlichia chaffeensis. 38
30274412 2018
71
Ehrlichia chaffeensis TRP120 nucleomodulin binds DNA with disordered tandem repeat domain. 38
29641592 2018
72
Detection of Ehrlichia, Anaplasma, and Babesia spp. in dogs of Cebu, Philippines. 38
29479151 2018
73
Serum antioxidant capacity and oxidative damage in clinical and subclinical canine ehrlichiosis. 38
28628845 2017
74
Prevalence of Amblyomma gervaisi ticks on captive snakes in Tamil Nadu. 38
29114125 2017
75
Changes in serum proteins in dogs with Ehrlichia canis infection. 38
29042303 2017
76
Ehrlichia chaffeensis and Its Invasin EtpE Block Reactive Oxygen Species Generation by Macrophages in a DNase X-Dependent Manner. 38
29162709 2017
77
A genetic system for targeted mutations to disrupt and restore genes in the obligate bacterium, Ehrlichia chaffeensis. 38
29150636 2017
78
Canine Monocytic Ehrlichiosis among working dogs of organised kennels in India: A comprehensive analyses of clinico-pathology, serological and molecular epidemiological approach. 38
29254723 2017
79
[Occurrence of Ehrlichia canis in dogs living in Germany and comparison of direct and indirect diagnostic methods]. 38
28905983 2017
80
Molecular prevalence and haemato-biochemical profile of canine monocytic ehrlichiosis in dogs in and around Hisar, Haryana, India. 38
28848253 2017
81
First report of Ehrlichia infection in goats, China. 38
28705746 2017
82
Investigating the Adult Ixodid Tick Populations and Their Associated Anaplasma, Ehrlichia, and Rickettsia Bacteria at a Rocky Mountain Spotted Fever Hotspot in Western Tennessee. 38
28598270 2017
83
Sudden sensorineural hearing loss in human monocytic ehrlichiosis. 38
28846788 2017
84
Vector-Borne Pathogens in Stray Dogs in Northeastern Turkey. 38
28632488 2017
85
An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humans. 38
28602279 2017
86
Canine pancytopoenia in a Mediterranean region: a retrospective study of 119 cases (2005 to 2013). 38
28247969 2017
87
Cerebral haemorrhage as a clinical manifestation of human ehrlichiosis. 38
28751428 2017
88
Proposal to reclassify Ehrlichia muris as Ehrlichia muris subsp. muris subsp. nov. and description of Ehrlichia muris subsp. eauclairensis subsp. nov., a newly recognized tick-borne pathogen of humans. 38
28699575 2017
89
Therapeutic management of canine ehrlichiosis with aid of blood transfusion: a case report. 38
28615848 2017
90
Tick-Borne Emerging Infections: Ehrlichiosis and Anaplasmosis. 38
28457353 2017
91
Molecular investigation and phylogeny of Anaplasmataceae species infecting domestic animals and ticks in Corsica, France. 38
28645313 2017
92
Relative Risk for Ehrlichiosis and Lyme Disease in an Area Where Vectors for Both Are Sympatric, New Jersey, USA. 38
28518034 2017
93
Occurrence of Amblyomma americanum (Acari: Ixodidae) and Human Infection With Ehrlichia chaffeensis in Wisconsin, 2008-2015. 38
28011735 2017
94
Prevalence and Distribution of Human and Tick Infections with the Ehrlichia muris-Like Agent and Anaplasma phagocytophilum in Wisconsin, 2009-2015. 38
28055326 2017
95
Early diagnosis of Ehrlichia ewingii infection in a lung transplant recipient by peripheral blood smear. 38
28036138 2017
96
Detection of Borrelia miyamotoi and other tick-borne pathogens in human clinical specimens and Ixodes scapularis ticks in New York State, 2012-2015. 38
28131594 2017
97
High-Dose Filgrastim Treatment of Nonregenerative Pancytopenia Associated With Chronic Canine Ehrlichiosis. 38
28750787 2017
98
Clinical and hematobiochemical response in canine monocytic ehrlichiosis seropositive dogs of Punjab. 38
28344412 2017
99
Awareness of tick-borne disease and compliance with using tick preventive products of dog owners in Hong Kong. 38
28034594 2017
100
Genetic profiling for Anaplasma and Ehrlichia species in ticks collected in the Eastern Cape Province of South Africa. 38
28241784 2017
101
Endosymbiont interference and microbial diversity of the Pacific coast tick, Dermacentor occidentalis, in San Diego County, California. 38
28503372 2017
102
Cytopenias and clonal expansion of gamma/delta T-cells in a patient with anaplasmosis: a potential diagnostic pitfall. 38
28331130 2017
103
Scoring clinical signs can help diagnose canine visceral leishmaniasis in a highly endemic area in Brazil. 38
28076469 2017
104
The Eurasian otter (Lutra lutra) as a potential host for rickettsial pathogens in southern Italy. 38
28267780 2017
105
Role and Function of the Type IV Secretion System in Anaplasma and Ehrlichia Species. 38
29536364 2017
106
Molecular Detection of Tick-Borne Pathogen Diversities in Ticks from Livestock and Reptiles along the Shores and Adjacent Islands of Lake Victoria and Lake Baringo, Kenya. 38
28620610 2017
107
Molecular detection of Ehrlichia spp. in blood samples of dogs in southern Iran using polymerase chain reaction. 38
29326795 2017
108
Amblyomma americanum ticks infected with in vitro cultured wild-type and mutants of Ehrlichia chaffeensis are competent to produce infection in naïve deer and dogs. 38
27729288 2017
109
Infection by Mycobacterium bovis in a dog from Brazil. 38
27914739 2017
110
Efficacy of Tagetes minuta (Asteraceae) essential oil against Rhipicephalus sanguineus (Acari: Ixodidae) on infested dogs and in vitro. 38
27815656 2016
111
Tick-Borne Diseases in Turkey: A Review Based on One Health Perspective. 38
27977689 2016
112
Evaluation of clinical, biochemical and haematological markers in natural infection of canine monocytic ehrlichiosis. 38
27876946 2016
113
Molecular Survey of Anaplasma and Ehrlichia of Red Deer and Sika Deer in Gansu, China in 2013. 38
25660960 2016
114
The eye and tick-borne disease in the United States. 38
27585218 2016
115
Ehrlichia secretes Etf-1 to induce autophagy and capture nutrients for its growth through RAB5 and class III phosphatidylinositol 3-kinase. 38
27541856 2016
116
Human monocytic ehrlichiosis complicated by hemophagocytic lymphohistiocytosis and multi-organ dysfunction syndrome. 38
27575459 2016
117
Cardiac troponin I concentrations, electrocardiographic and echocardiographic variables remained unchanged in dogs experimentally infected with Ehrlichia canis. 38
27810200 2016
118
Molecular survey of Ehrlichia canis and Coxiella burnetii infections in wild mammals of southern Italy. 38
27535678 2016
119
Severe human monocytic ehrlichiosis presenting with altered mental status and seizures. 38
27758794 2016
120
Emerging Vector-Borne Diseases. 38
27929218 2016
121
Use of Extracorporeal Support in Hemophagocytic Lymphohistiocytosis Secondary to Ehrlichiosis. 38
27633921 2016
122
Canine bicavitary carcinomatosis with transient needle tract metastasis diagnosed by multiplex immunocytochemistry. 38
27571570 2016
123
Ehrlichioses: An Important One Health Opportunity. 38
29056728 2016
124
Ehrlichiosis Induced Aseptic Meningitis and Second-Degree Heart Block in an Adolescent Male. 38
27097347 2016
125
Sequence determinants spanning -35 motif and AT-rich spacer region impacting Ehrlichia chaffeensis Sigma 70-dependent promoter activity of two differentially expressed p28 outer membrane protein genes. 38
27402867 2016
126
Interstitial pneumonia and pulmonary hypertension associated with suspected ehrlichiosis in a dog. 38
27388158 2016
127
Isolation and Short-Term Persistence of Ehrlichia ewingii in Cell Culture. 38
27228133 2016
128
Serological and molecular investigation of Ehrlichia spp. and Anaplasma spp. in ticks and blood of dogs, in the Thrace Region of Turkey. 38
26961274 2016
129
Ehrlichia chaffeensis TRP120 Activates Canonical Notch Signaling To Downregulate TLR2/4 Expression and Promote Intracellular Survival. 38
27381289 2016
130
Countrywide serological evaluation of canine prevalence for Anaplasma spp., Borrelia burgdorferi (sensu lato), Dirofilaria immitis and Ehrlichia canis in Mexico. 38
27474020 2016
131
Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs. 38
27430425 2016
132
Molecular characterization of Ehrlichia canis infecting dogs, Buenos Aires. 38
27236582 2016
133
Minimum infection rate of Ehrlichia minasensis in Rhipicephalus microplus and Amblyomma sculptum ticks in Brazil. 38
27084673 2016
134
Ehrlichiosis in Household Dogs and Parasitized Ticks in Kerman-Iran: Preliminary Zoonotic Risk Assessment. 38
27308282 2016
135
Use of Peptide-Based Enzyme-Linked Immunosorbent Assay followed by Immunofluorescence Assay To Document Ehrlichia chaffeensis as a Cause of Febrile Illness in Nicaragua. 38
27053675 2016
136
Quantitative and qualitative leukocyte abnormalities in dogs with experimental and naturally occurring acute canine monocytic ehrlichiosis. 38
27142117 2016
137
Ultrasonographic changes in dogs naturally infected with tick borne intracellular diseases. 38
27413287 2016
138
Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix(®)) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs. 38
27317101 2016
139
Growth of Ehrlichia canis, the causative agent of canine monocytic ehrlichiosis, in vector and non-vector ixodid tick cell lines. 38
26837859 2016
140
Fatal Monocytic Ehrlichiosis in Woman, Mexico, 2013. 38
27088220 2016
141
A Clinical Review of Tick-Borne Diseases in Arkansas. 38
27263175 2016
142
Expanded Geographic Distribution and Clinical Characteristics of Ehrlichia ewingii Infections, United States. 38
27089171 2016
143
Incident Tick-Borne Infections in a Cohort of North Carolina Outdoor Workers. 38
27008102 2016
144
Efficacy and speed of kill of a topically applied formulation of dinotefuran-permethrin-pyriproxyfen against weekly tick infestations with Rhipicephalus sanguineus (sensu lato) on dogs. 38
27183970 2016
145
Tick-Borne Illnesses. 38
26963018 2016
146
Specifying Pathogen Associations of Amblyomma maculatum (Acari: Ixodidae) in Western Tennessee. 38
26744464 2016
147
[EPIDEMIOLOGIC SITUATION BY NATURAL-FOCI INFECTIONS IN THE CRIMEA FEDERAL DISTRICT IN 2014-2015]. 38
27228673 2016
148
Molecular identification and characterization of Anaplasma platys and Ehrlichia canis in dogs in Mexico. 38
26615872 2016
149
Acute phase protein and antioxidant responses in dogs with experimental acute monocytic ehrlichiosis treated with rifampicin. 38
26854345 2016
150
Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Rhipicephalus sanguineus s.l. on dogs. 38
26896456 2016
151
Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Amblyomma americanum on dogs. 38
26897175 2016
152
Undetermined Human Ehrlichiosis and Anaplasmosis in the United States, 2008-2012: A Catch-All for Passive Surveillance. 38
26621564 2016
153
Development of Structure-Based Vaccines for Ehrlichiosis. 38
27076151 2016
154
Vaccination with an Attenuated Mutant of Ehrlichia chaffeensis Induces Pathogen-Specific CD4+ T Cell Immunity and Protection from Tick-Transmitted Wild-Type Challenge in the Canine Host. 38
26841025 2016
155
Comparative Genomics of the Zoonotic Pathogen Ehrlichia chaffeensis Reveals Candidate Type IV Effectors and Putative Host Cell Targets. 38
28180111 2016
156
NK Cell-Mediated Regulation of Protective Memory Responses against Intracellular Ehrlichial Pathogens. 38
27092553 2016
157
Prevalence of antibodies against Ehrlichia spp. and Orientia tsutsugamushi in small mammals around harbors in Taiwan. 38
26817445 2016
158
Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin. 38
26918212 2016
159
Increasing Incidence of Ehrlichiosis in the United States: A Summary of National Surveillance of Ehrlichia chaffeensis and Ehrlichia ewingii Infections in the United States, 2008-2012. 38
26621561 2016
160
Hacker within! Ehrlichia chaffeensis Effector Driven Phagocyte Reprogramming Strategy. 38
27303657 2016
161
Gray Wolf Exposure to Emerging Vector-Borne Diseases in Wisconsin with Comparison to Domestic Dogs and Humans. 38
27898670 2016
162
Molecular Detection of Anaplasma spp. and Ehrlichia spp. in Ruminants from Twelve Provinces of China. 38
28096822 2016
163
Vector-Borne Diseases in Stray Dogs in Peninsular Malaysia and Molecular Detection of Anaplasma and Ehrlichia spp. from Rhipicephalus sanguineus (Acari: Ixodidae) Ticks. 38
26494821 2016
164
The infection of reintroduced ruminants - Bison bonasus and Alces alces - with Anaplasma phagocytophilum in northern Poland. 38
26408585 2015
165
Borrelia miyamotoi Disease: Neither Lyme Disease Nor Relapsing Fever. 38
26593262 2015
166
Development and evaluation of a loop-mediated isothermal amplification assay for detection of Ehrlichia canis DNA in naturally infected dogs using the p30 gene. 38
26782434 2015
167
Seroprevalence and Risk Factors of Ehrlichia canis Infection among Companion Dogs of Mashhad, North East of Iran, 2009-2010. 38
26623430 2015
168
Butyrylcholinesterase as a marker of inflammation and liver injury in the acute and subclinical phases of canine ehrlichiosis. 38
26616656 2015
169
EtpE Binding to DNase X Induces Ehrlichial Entry via CD147 and hnRNP-K Recruitment, Followed by Mobilization of N-WASP and Actin. 38
26530384 2015
170
The shadows of a ghost: a survey of canine leishmaniasis in Presidente Prudente and its spatial dispersion in the western region of São Paulo state, an emerging focus of visceral leishmaniasis in Brazil. 38
26503368 2015
171
Diseases Transmitted by Cats. 38
26542039 2015
172
Recognition of and Prompt Treatment for Tick-Borne Infections in Children. 38
26188606 2015
173
A Tick Vector Transmission Model of Monocytotropic Ehrlichiosis. 38
25737562 2015
174
Arthropod-Borne Diseases: The Camper's Uninvited Guests. 38
26350321 2015
175
The genus Anaplasma: new challenges after reclassification. 38
26601458 2015
176
The perils of country life: human monocytic ehrlichiosis. 38
25912197 2015
177
Attenuated Mutants of Ehrlichia chaffeensis Induce Protection against Wild-Type Infection Challenge in the Reservoir Host and in an Incidental Host. 38
25916990 2015
178
Geographical and Temporal Correlations in the Incidence of Lyme Disease, RMSF, Ehrlichiosis, and Coccidioidomycosis with Search Data. 38
25756797 2015
179
Recombinant gp19 as a potential antigen for detecting anti-Ehrlichia canis antibodies in dog sera. 38
26291145 2015
180
Hematobiochemical changes in ehrlichiosis in dogs of Anand region, Gujarat. 38
27065635 2015
181
Perspectives on the pathogenesis and treatment of canine monocytic ehrlichiosis (Ehrlichia canis). 38
25957922 2015
182
First record of autochthonous canine ehrlichiosis caused by Ehrlichia canis in Romania. 38
25867940 2015
183
Serological and molecular analysis of feline vector-borne anaplasmosis and ehrlichiosis using species-specific peptides and PCR. 38
26062723 2015
184
Serum DHEA-S increases in dogs naturally infected with Ehrlichia canis. 38
25956636 2015
185
Serodetection of Ehrlichia canis amongst dogs in central Namibia. 38
26244587 2015
186
Effects of doxycycline on haematology, blood chemistry and peripheral blood lymphocyte subsets of healthy dogs and dogs naturally infected with Ehrlichia canis. 38
25957920 2015
187
Synovial fluid cytology in experimental acute canine monocytic ehrlichiosis (Ehrlichia canis). 38
25770893 2015
188
The role of CD8 T lymphocytes in rickettsial infections. 38
25823954 2015
189
Canine ehrlichiosis: prevalence and epidemiology in northeast Brazil. 38
26083691 2015
190
Total protein concentration and diagnostic test results for gray wolf (Canis lupus) serum using Nobuto filter paper strips. 38
25574804 2015
191
Molecular identification of Ehrlichia species and host bloodmeal source in Amblyomma americanum L. from two locations in Tennessee, United States. 38
25682494 2015
192
The efficacy of a generic doxycycline tablet in the treatment of canine monocytic ehrlichiosis. 38
26018824 2015
193
An atypical Toxoplasma gondii genotype in a rural Brazilian dog co-infected with Leishmania (Viannia) braziliensis. 38
25992942 2015
194
Molecular detection of Anaplasma platys and Ehrlichia canis in dogs from Kabylie, Algeria. 38
25583345 2015
195
Comparison of the acute phase protein and antioxidant responses in dogs vaccinated against canine monocytic ehrlichiosis and naive-challenged dogs. 38
25888870 2015
196
First identification of Anaplasma platys in the blood of dogs from French Guiana. 38
25700049 2015
197
Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe. 38
25649069 2015
198
An animal model of a newly emerging human ehrlichiosis. 38
24990203 2015
199
Hemophagocytic lymphohistiocytosis induced by monocytic ehrlichiosis. 38
25449215 2015
200
Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae. 38
25481711 2015
201
Canine vector-borne co-infections: Ehrlichia canis and Hepatozoon canis in the same host monocytes. 38
25560923 2015
202
Molecular evidence of potential novel spotted fever group rickettsiae, Anaplasma and Ehrlichia species in Amblyomma ticks parasitizing wild snakes. 38
25889376 2015
203
Hemophagocytic lymphohistiocytosis secondary to ehrlichiosis in a child. 38
24691079 2015
204
[Relapsing (recurrent) disease caused by Borrelia miyamotoi]. 38
26821411 2015
205
A Coxiella-like endosymbiont is a potential vitamin source for the Lone Star tick. 38
25618142 2015
206
Mutations in Ehrlichia chaffeensis Causing Polar Effects in Gene Expression and Differential Host Specificities. 38
26186429 2015
207
Sinus bradycardia: can we blame ehrlichiosis? 38
25232718 2015
208
Diagnosis and incidence risk of clinical canine monocytic ehrlichiosis under field conditions in Southern Europe. 38
25561342 2015
209
Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis, and ehrlichiosis in an Australian cohort. 38
25565883 2015
210
Molecular Diagnosis of Ehrlichia canis in Dogs and Ticks Rhipicephalus sanguineus (Acari: Ixodidae) in Yucatan, Mexico. 38
26336286 2015
211
Habitat and Vegetation Variables Are Not Enough When Predicting Tick Populations in the Southeastern United States. 38
26656122 2015
212
Occurrence of Ehrlichia canis in free-living primates of the genus Callithrix. 38
25909257 2015
213
Comparative Evaluation of the Vector Competence of Four South American Populations of the Rhipicephalus sanguineus Group for the Bacterium Ehrlichia canis, the Agent of Canine Monocytic Ehrlichiosis. 38
26414283 2015
214
Prevalence of Rickettsiales in ticks removed from the skin of outdoor workers in North Carolina. 38
25533148 2014
215
Evaluation of a commercial in-clinic point-of-care polymerase chain reaction test for Ehrlichia canis DNA in artificially infected dogs. 38
25453243 2014
216
Ehrlichia chaffeensis proliferation begins with NtrY/NtrX and PutA/GlnA upregulation and CtrA degradation induced by proline and glutamine uptake. 38
25425236 2014
217
Mixed cryoglobulinemia and secondary membranoproliferative glomerulonephritis associated with ehrlichiosis. 38
28509195 2014
218
Co-circulation of multiple species of Rickettsiales bacteria in one single species of hard ticks in Shenyang, China. 38
25131152 2014
219
Macrophage activation syndrome secondary to human monocytic ehrlichiosis. 38
25332563 2014
220
Social-ecological factors determine spatial variation in human incidence of tick-borne ehrlichiosis. 38
24280291 2014
221
Molecular detection and treatment of tick-borne pathogens in domestic dogs in Khon Kaen, northeastern Thailand. 38
25417519 2014
222
A novel Ehrlichia genotype strain distinguished by the TRP36 gene naturally infects cattle in Brazil and causes clinical manifestations associated with ehrlichiosis. 38
24915874 2014
223
Heartland virus-associated death in tennessee. 38
24917656 2014
224
Detection of Ehrlichia canis in canine blood samples by real-time fluorescence resonance energy transfer (FRET) PCR and melting curve analysis. 38
25417518 2014
225
Tick-borne pathogens of potential zoonotic importance in the southern African Region. 38
25685942 2014
226
Experimental infection of Rhipicephalus sanguineus with Ehrlichia chaffeensis. 38
24894131 2014
227
Colorimetric detection of Ehrlichia canis via nucleic acid hybridization in gold nano-colloids. 38
25111239 2014
228
[Prevalence, prevention and treatment of human monocytic ehrlichiosis in China]. 38
25376694 2014
229
Intravascular persistence of Anaplasma platys, Ehrlichia chaffeensis, and Ehrlichia ewingii DNA in the blood of a dog and two family members. 38
24984562 2014
230
Use of an automated system for detection of canine serum antibodies against Ehrlichia canis glycoprotein 36. 38
25027497 2014
231
Temporal and spatial variation in Anaplasma phagocytophilum infection in Swedish moose (Alces alces). 38
24001524 2014
232
Acute respiratory distress syndrome in human granulocytic ehrlichiosis. 38
25672061 2014
233
High throughput pyrosequencing technology for molecular differential detection of Babesia vogeli, Hepatozoon canis, Ehrlichia canis and Anaplasma platys in canine blood samples. 38
24704311 2014
234
In vitro culture and structural differences in the major immunoreactive protein gp36 of geographically distant Ehrlichia canis isolates. 38
24713279 2014
235
Ehrlichia and spotted fever group Rickettsiae surveillance in Amblyomma americanum in Virginia through use of a novel six-plex real-time PCR assay. 38
24746145 2014
236
Intracytoplasmic granulocytic morulae counts on confirmed cases of ehrlichiosis/anaplasmosis in the Northeast. 38
24713739 2014
237
Canine infection with Dirofilaria immitis, Borrelia burgdorferi, Anaplasma spp., and Ehrlichia spp. in the United States, 2010-2012. 38
24886589 2014
238
Molecular diagnosis and species identification of Ehrlichia and Anaplasma infections in dogs from Panama, Central America. 38
24746012 2014
239
Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis. 38
24491580 2014
240
[Serological verification of tick-borne encephalitis cases in the Altai Republic]. 38
25296419 2014
241
[Actual diagnosis, treatment and prevention of human granulocytic anaplasmosis]. 38
24868903 2014
242
Pancytopenia in Lyme disease. 38
24596410 2014
243
[Asymptomatic human infection from contact with dogs: a case of human ehrlichiosis]. 38
24603998 2014
244
Serum canine pancreatic lipase immunoreactivity in experimentally induced and naturally occurring canine monocytic ehrlichiosis (Ehrlichia canis). 38
24530039 2014
245
Rickettsiae and ehrlichiae within a city park: is the urban dweller at risk? 38
24528097 2014
246
Usefulness of a rapid immuno-migration test for the detection of canine monocytic ehrlichiosis in Africa. 38
24252768 2014
247
Clinical history and hematological findings among canines with monocytic ehrlichiosis. 38
24964665 2014
248
Doxycycline desensitization for a suspected case of ehrlichiosis. 38
24565779 2014
249
Temporal and Spatial Distribution of Tick-Borne Disease Cases among Humans and Canines in Illinois (2000-2009). 38
25452696 2014
250
Ehrlichia chaffeensis infection in the reservoir host (white-tailed deer) and in an incidental host (dog) is impacted by its prior growth in macrophage and tick cell environments. 38
25303515 2014
251
Bayesian spatio-temporal analysis and geospatial risk factors of human monocytic ehrlichiosis. 38
24992684 2014
252
Rural residents in China are at increased risk of exposure to tick-borne pathogens Anaplasma phagocytophilum and Ehrlichia chaffeensis. 38
24877080 2014
253
Emerging Vector-Borne Diseases - Incidence through Vectors. 38
25520951 2014
254
A case of human monocytic ehrlichiosis in Serbia. 38
24684037 2014
255
Detection of Ehrlichia canis in domestic cats in the central-western region of Brazil. 38
25242952 2014
256
The spreading process of Ehrlichia canis in macrophages is dependent on actin cytoskeleton, calcium and iron influx and lysosomal evasion. 38
24378068 2014
257
Surveillance for Ehrlichia canis, Anaplasma phagocytophilum, Borrelia burgdorferi, and Dirofilaria immitis in Dogs From Three Cities in Colombia. 38
24604443 2014
258
Vector-borne pathogens in dogs from Costa Rica: first molecular description of Babesia vogeli and Hepatozoon canis infections with a high prevalence of monocytic ehrlichiosis and the manifestations of co-infection. 38
24315693 2014
259
The prevalence of Ehrlichia canis, Anaplasma platys and Babesia spp. in dogs in Nueva Ecija, Philippines based on multiplex polymerase chain reaction (mPCR) assay. 38
25706424 2014
260
Complete Genome Sequence of Ehrlichia muris Strain AS145T, a Model Monocytotropic Ehrlichia Strain. 38
24482514 2014
261
A case of ocular canine transmissible venereal tumor. 38
24381345 2014
262
Myocarditis after trimethoprim/sulfamethoxazole treatment for ehrlichiosis. 38
24274783 2013
263
Recombinant Ehrlichia P29 protein induces a protective immune response in a mouse model of ehrlichiosis. 38
24144475 2013
264
Study of ehrlichiosis in kennel dogs under treatment and prevention during seven months in Dakar (Senegal). 38
24018180 2013
265
Prevalence of borreliosis, anaplasmosis, ehrlichiosis and Dirofilaria immitis in dogs and vectors in Voronezh Reserve (Russia). 38
24054985 2013
266
Inhibitory effect of interferon gamma on frequency of Ehrlichia canis-infected cells in vitro. 38
24148826 2013
267
Detection of Ehrlichia canis and Anaplasma platys DNA using multiplex PCR. 38
24107211 2013
268
Hematological values associated to the serological and molecular diagnostic in cats suspected of Ehrlichia canis infection. 38
24473870 2013
269
Influence of experimental canine ehrlichiosis on the E-ADA activity and purine levels in serum and possible functional correlations with pathogenesis. 38
23907060 2013
270
Autochthonous canine babesiosis caused by Babesia canis canis in Latvia. 38
23582665 2013
271
Serological survey of Ehrlichia species in dogs, horses and humans: zoonotic scenery in a rural settlement from southern Brazil. 38
24037288 2013
272
Tick-borne trauma: an unusual presentation of anaplasmosis. 38
24195180 2013
273
Efficacy of rifampicin in the treatment of experimental acute canine monocytic ehrlichiosis. 38
23475646 2013
274
Comparison of a real-time PCR method with serology and blood smear analysis for diagnosis of human anaplasmosis: importance of infection time course for optimal test utilization. 38
23637292 2013
275
Ehrlichiosis presenting with toxic shock-like syndrome and secondary hemophagocytic lymphohistiocytosis. 38
23808094 2013
276
[Ehrlichia bacteria and ehrlichiosis]. 38
24125623 2013
277
Spatial and seasonal variation in the prevalence of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in questing Ixodes ricinus ticks in Norway. 38
23786850 2013
278
Genetic diversity of Ehrlichia canis in Brazil. 38
23490559 2013
279
A confirmed Ehrlichia ewingii infection likely acquired through platelet transfusion. 38
23511303 2013
280
Multiorgan failure related to human monocytic ehrlichiosis. 38
23704428 2013
281
Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock. 38
23478316 2013
282
MyD88 signaling in CD4 T cells promotes IFN-γ production and hematopoietic progenitor cell expansion in response to intracellular bacterial infection. 38
23526822 2013
283
Distribution of tick-borne diseases in China. 38
23617899 2013
284
Serosurvey for tick-borne diseases in dogs from the Eastern Amazon, Brazil. 38
23802236 2013
285
Seropositivity rates for agents of canine vector-borne diseases in Spain: a multicentre study. 38
23607428 2013
286
First description of natural Ehrlichia canis and Anaplasma platys infections in dogs from Argentina. 38
23273677 2013
287
Multiple myeloma in a dog with multiple concurrent infectious diseases and persistent polyclonal gammopathy. 38
23278475 2013
288
Molecular evidence of Ehrlichia canis and Rickettsia massiliae in ixodid ticks of carnivores from South Hungary. 38
23439290 2013
289
Targeted and random mutagenesis of Ehrlichia chaffeensis for the identification of genes required for in vivo infection. 38
23459099 2013
290
Aggregate-reactivation activity of the molecular chaperone ClpB from Ehrlichia chaffeensis. 38
23667479 2013
291
TLR2 and Nod2 mediate resistance or susceptibility to fatal intracellular Ehrlichia infection in murine models of ehrlichiosis. 38
23526993 2013
292
Ehrlichia chaffeensis uses its surface protein EtpE to bind GPI-anchored protein DNase X and trigger entry into mammalian cells. 38
24098122 2013
293
Ehrlichia chaffeensis replication sites in adult Drosophila melanogaster. 38
23306065 2013
294
Transcription of Ehrlichia chaffeensis genes is accomplished by RNA polymerase holoenzyme containing either sigma 32 or sigma 70. 38
24278458 2013
295
Ehrlichiosis, babesiosis, anaplasmosis and hepatozoonosis in dogs from St. Kitts, West Indies. 38
23335965 2013
296
Frequency and Clinical Epidemiology of Canine Monocytic Ehrlichiosis in Dogs Infested with Ticks from Sinaloa, Mexico. 38
26464910 2013
297
Seroprevalence rates of antibodies against Leishmania infantum and other protozoan and rickettsial parasites in dogs. 38
24252965 2013
298
Detection of A. phagocytophilum and E. chaffeensis in patient and mouse blood and ticks by a duplex real-time PCR assay. 38
24023963 2013
299
Using administrative medical claims data to supplement state disease registry systems for reporting zoonotic infections. 38
22811492 2013
300
The efficacy of Advantix® to prevent transmission of Ehrlichia canis to dogs by Rhipicephalus sanguineus ticks. 38
24135158 2013
301
Vector-borne disease surveillance in puerto rico: pathogen prevalence rates in canines ? Implications for public health and the u.s. Military ? Applying the one health concept. 38
23817880 2013
302
[Disseminated intravascular coagulopathy in a dog with Angiostrongylus vasorum infection]. 38
24326880 2013
303
Evaluation of an attenuated strain of Ehrlichia canis as a vaccine for canine monocytic ehrlichiosis. 38
23072894 2012
304
First detection of Ehrlichia canis in Rhipicephalus bursa ticks in Sardinia, Italy. 38
23140896 2012
305
Evaluation of lymphocyte populations in dogs naturally infected by Ehrlichia canis with and without clinical signs. 38
23168046 2012
306
Ehrlichia canis in Rhipicephalus sanguineus ticks in the Ivory Coast. 38
23141106 2012
307
The comparison of spatial variation and risk factors between mosquito-borne and tick-borne diseases: Seroepidemiology of Ehrlichia canis, Anaplasma species, and Dirofilaria immitis in dogs. 38
22925931 2012
308
Serum cardiac troponin I concentrations in naturally occurring myelosuppressive and non-myelosuppressive canine monocytic ehrlichiosis. 38
22633176 2012
309
Ehrlichiosis and zoonotic anaplasmosis in suburban areas of Beijing, China. 38
23025695 2012
310
Identification of critical host mitochondrion-associated genes during Ehrlichia chaffeensis infections. 38
22851751 2012
311
In silico characterization of three two-component systems of Ehrlichia canis and evaluation of a natural plant-derived inhibitor. 38
23096683 2012
312
Occurrence of Ehrlichia canis and Anaplasma platys in household dogs from northern Parana. 38
23207986 2012
313
[Molecular identification of Ehrlichia canis in a dog from Arica, Chile]. 38
23282495 2012
314
Epidemiology of ehrlichiosis and anaplasmosis among American Indians in the United States, 2000-2007. 38
22826495 2012
315
Comparing spatio-temporal clusters of arthropod-borne infections using administrative medical claims and state reported surveillance data. 38
22749206 2012
316
The role of cytoskeleton, components of inositol phospholipid signaling pathway and iron in Ehrlichia canis in vitro proliferation. 38
22415481 2012
317
Ehrlichia chaffeensis presenting with bilateral anterior thigh pain (Louria's sign). 38
22520448 2012
318
Prevention of vector transmitted diseases with clove oil insect repellent. 38
22703681 2012
319
Tick-borne diseases in Minnesota: an update. 38
22953474 2012
320
Antigen-driven induction of polyreactive IgM during intracellular bacterial infection. 38
22730531 2012
321
Penicillin-binding protein of Ehrlichia chaffeensis: cytokine induction through MyD88-dependent pathway. 38
22539814 2012
322
Ehrlichia type IV secretion effector ECH0825 is translocated to mitochondria and curbs ROS and apoptosis by upregulating host MnSOD. 38
22348527 2012
323
Identification of Ehrlichia spp in canines in Thailand. 38
23077820 2012
324
Evaluation of peripheral blood lymphocyte subsets in family-owned dogs naturally infected by Ehrlichia canis. 38
22521727 2012
325
Experimental Ehrlichia canis infection changes acute-phase proteins. 38
23070428 2012
326
Ehrlichioses: anaplasmosis and human ehrlichiosis. 38
22608121 2012
327
Ehrlichia chaffeensis human monocytic ehrlichiosis with pancytopenia. 38
22497260 2012
328
Immune mediators of protective and pathogenic immune responses in patients with mild and fatal human monocytotropic ehrlichiosis. 38
22607204 2012
329
Molecular and serological detection of Ehrlichia canis and Babesia vogeli in dogs in Colombia. 38
22130333 2012
330
Fatal ehrlichial myocarditis in a healthy adolescent: a case report and review of the literature. 38
22354925 2012
331
Recurrent fever of unknown origin (FUO): aseptic meningitis, hepatosplenomegaly, pericarditis and a double quotidian fever due to juvenile rheumatoid arthritis (JRA). 38
21453973 2012
332
Vector-borne diseases--constant challenge for practicing veterinarians: recommendations from the CVBD World Forum. 38
22433172 2012
333
Evaluation of clinical specimens for Rickettsia, Bartonella, Borrelia, Coxiella, Anaplasma, Franciscella and Diplorickettsia positivity using serological and molecular biology methods. 38
22098390 2012
334
Seroprevalence of Ehrlichia canis, Ehrlichia chaffeensis and Ehrlichia ewingii in dogs in North America. 38
22316160 2012
335
Saliva, salivary gland, and hemolymph collection from Ixodes scapularis ticks. 38
22371172 2012
336
Transmission electron microscopy reveals distinct macrophage- and tick cell-specific morphological stages of Ehrlichia chaffeensis. 38
22615806 2012
337
Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset. 38
23155374 2012
338
Molecular and serological detection of Ehrlichia spp. in cats on São Luís Island, Maranhão, Brazil. 38
22534943 2012
339
An assessment of whole blood and fractions by nested PCR as a DNA source for diagnosing canine ehrlichiosis and anaplasmosis. 38
22973174 2012
340
Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an overview. 38
22393303 2012
341
A case report of human granulocytic anaplasmosis (ehrlichiosis) in pregnancy and a literature review of tick-borne diseases in the United States during pregnancy. 38
22192463 2011
342
Insights into the CtrA regulon in development of stress resistance in obligatory intracellular pathogen Ehrlichia chaffeensis. 38
22014113 2011
343
Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors. 38
21930764 2011
344
Short report: Race and rickettsiae: a United States perspective. 38
22144456 2011
345
Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis. 38
22030371 2011
346
Seroprevalence and risk factors to Ehrlichia spp. and Rickettsia spp. in dogs from the Pantanal Region of Mato Grosso State, Brazil. 38
22108015 2011
347
Evaluation of 4-poster acaricide applicators to manage tick populations associated with disease risk in a Tennessee retirement community. 38
22129412 2011
348
Infection prevalences of common tick-borne pathogens in adult lone star ticks (Amblyomma americanum) and American dog ticks (Dermacentor variabilis) in Kentucky. 38
21976578 2011
349
Use of ELISA employing homologous and heterologous antigens for the detection of IgG and subclasses (IgG1 and IgG2) in the diagnosis of canine visceral leishmaniasis. 38
22012455 2011
350
Fatal human monocytic ehrlichiosis: a case study. 38
21279705 2011
351
Retrospective evaluation of laboratory data on canine vector-borne infections from the years 2004-2008. 38
21950219 2011
352
Canine vector-borne disease in travelled dogs in Germany--a retrospective evaluation of laboratory data from the years 2004-2008. 38
21565447 2011
353
Tyrosine-phosphorylated Ehrlichia chaffeensis and Ehrlichia canis tandem repeat orthologs contain a major continuous cross-reactive antibody epitope in lysine-rich repeats. 38
21606187 2011
354
First isolation and molecular characterization of Ehrlichia canis in Costa Rica, Central America. 38
20723954 2011
355
Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota, 2009. 38
21812671 2011
356
Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000-2007. 38
21734137 2011
357
Pilot study assessing the effectiveness of long-lasting permethrin-impregnated clothing for the prevention of tick bites. 38
21395420 2011
358
Risk factors and clinical disorders of canine ehrlichiosis in the South of Bahia, Brazil. 38
21961750 2011
359
Molecular survey of Anaplasma phagocytophilum and Ehrlichia canis in red foxes (Vulpes vulpes) from central Italy. 38
21719836 2011
360
Serum acute phase proteins as clinical phase indicators and outcome predictors in naturally occurring canine monocytic ehrlichiosis. 38
21564293 2011
361
Emergence of bovine ehrlichiosis in Belgian cattle herds. 38
21771546 2011
362
[Serology of Lyme borreliosis and human granulocytic ehrlichiosis in 2005-2010]. 38
21838175 2011
363
Detection of Leishmania amastigotes in peripheral blood from four dogs--Short communication. 38
21665574 2011
364
Experimental primary and secondary infections of domestic dogs with Ehrlichia ewingii. 38
21397411 2011
365
Ehrlichia-induced hemophagocytic lymphohistiocytosis in two children. 38
21298756 2011
366
Isolation and characterization of Ehrlichia chaffeensis RNA polymerase and its use in evaluating p28 outer membrane protein gene promoters. 38
21513529 2011
367
The immunopathology of canine vector-borne diseases. 38
21489234 2011
368
One health: the importance of companion animal vector-borne diseases. 38
21489237 2011
369
Prevalence of anti-platelet antibodies in dogs naturally co-infected by Leishmania infantum and Ehrlichia canis. 38
20456989 2011
370
Gammopathy in a Spanish dog infected with Bartonella henselae. 38
21906064 2011
371
Diagnosis of canine monocytotropic ehrlichiosis (Ehrlichia canis): an overview. 38
20226700 2011
372
Cytologic patterns of lymphadenopathy in canine monocytic ehrlichiosis. 38
21291487 2011
373
Diagnosis of canine monocytic ehrlichiosis: development of advanced techniques to combat a global disease. 38
20580578 2011
374
Candidatus Neoehrlichia mikurensis infection identified in 2 hematooncologic patients: benefit of molecular techniques for rare pathogen detection. 38
21353949 2011
375
An acarologic survey and Amblyomma americanum distribution map with implications for tularemia risk in Missouri. 38
21363979 2011
376
Small risk of developing symptomatic tick-borne diseases following a tick bite in The Netherlands. 38
21310036 2011
377
Structure-based vaccines provide protection in a mouse model of ehrlichiosis. 38
22114733 2011
378
Emerging incidence of Lyme borreliosis, babesiosis, bartonellosis, and granulocytic ehrlichiosis in Australia. 38
22267937 2011
379
Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-γ signaling. 38
21149601 2011
380
Ehrlichiosis in Brazil. 38
21439224 2011
381
Monocytic ehrlichiosis in dogs. 38
21957751 2011
382
Ehrlichia chaffeensis transcriptome in mammalian and arthropod hosts reveals differential gene expression and post transcriptional regulation. 38
21915290 2011
383
Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies. 38
21276277 2011
384
Ehrlichia canis (Jaboticabal strain) induces the expression of TNF-α in leukocytes and splenocytes of experimentally infected dogs. 38
21439237 2011
385
Prevalence of Ehrlichia muris in Wisconsin Deer Ticks Collected During the Mid 1990s. 38
21643499 2011
386
Transient activation of hematopoietic stem and progenitor cells by IFNγ during acute bacterial infection. 38
22194881 2011
387
Effect of desmopressin on immune-mediated haemorrhagic disorders due to canine monocytic ehrlichiosis: a preliminary study. 38
21108506 2010
388
Efficacy of a doxycycline treatment regimen initiated during three different phases of experimental ehrlichiosis. 38
20921310 2010
389
Exit mechanisms of the intracellular bacterium Ehrlichia. 38
21187937 2010
390
Sequence and phylogenetic analysis of the gp200 protein of Ehrlichia canis from dogs in Taiwan. 38
21113103 2010
391
Ehrlichiosis and anaplasmosis in dogs and cats. 38
20933140 2010
392
[PCR detection of the causative agents of infections transmitted by ticks on the Kamchatka Peninsula]. 38
21400710 2010
393
Invasive honeysuckle eradication reduces tick-borne disease risk by altering host dynamics. 38
20937859 2010
394
Tickborne infections in the southern United States. 38
20697259 2010
395
Ehrlichia ewingii infection and exposure rates in dogs from the southcentral United States. 38
20541322 2010
396
Cyclic di-GMP signaling regulates invasion by Ehrlichia chaffeensis of human monocytes. 38
20562302 2010
397
Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome. 38
20616341 2010
398
MyD88-dependent signaling contributes to host defense against ehrlichial infection. 38
20668698 2010
399
Molecular and serologic detection of Ehrlichia spp. in endangered Brazilian wild captive felids. 38
20688716 2010
400
Serologic evidence of equine granulocytic anaplasmosis in horses from central West Brazil. 38
20943015 2010
401
Survey for tick-borne zoonoses in the state of Espirito Santo, southeastern Brazil. 38
20595502 2010
402
An insight into the sialotranscriptome of the brown dog tick, Rhipicephalus sanguineus. 38
20650005 2010
403
Prevalence of Ehrlichia chaffeensis and Ehrlichia ewingii in ticks from Tennessee. 38
19877819 2010
404
SDetection of vector-borne agents in lone star ticks, Amblyomma americanum (Acari: Ixodidae), from Mississippi. 38
20496596 2010
405
Absence of myelofibrosis in dogs with myelosuppression induced by Ehrlichia canis infection. 38
19906384 2010
406
Severe ehrlichia infection in pediatric oncology and stem cell transplant patients. 38
20052776 2010
407
Microchip electrophoretic separation for the fast diagnosis of Anaplasma phagocytophilum infection in cattle. 38
20175090 2010
408
Tick bites and skin rashes. 38
20071986 2010
409
Prevalence of canine ehrlichiosis in Perak State, peninsular Malaysia. 38
20562808 2010
410
[Seroprevalence anti-Ehrlichia canis antibodies in dogs of Cuiabá, Mato Grosso]. 38
20624348 2010
411
Sensitivity evaluation of a single-step PCR assay using Ehrlichia canis p28 gene as a target and its application in diagnosis of canine ehrlichiosis. 38
20624341 2010
412
Ehrlichia canis morulae and DNA detection in whole blood and spleen aspiration samples. 38
20624346 2010
413
Prevalence of ehrlichial infection among dogs and ticks in Northeastern Brazil. 38
20624344 2010
414
Ticks (Acari: Ixodidae) on dogs from Uberlândia, Minas Gerais, Brazil. 38
20537111 2010
415
Canine vector-borne diseases in India: a review of the literature and identification of existing knowledge gaps. 38
20377862 2010
416
Human ehrlichiosis and anaplasmosis. 38
20513551 2010
417
Population genetics of Amblyomma americanum (Acari: Ixodidae) collected from Arkansas. 38
20380295 2010
418
The natural history of Anaplasma phagocytophilum. 38
19811878 2010
419
Factors contributing to emergence of Ehrlichia and Anaplasma spp. as human pathogens. 38
19836890 2010
420
Natural history of Ehrlichia chaffeensis: vertebrate hosts and tick vectors from the United States and evidence for endemic transmission in other countries. 38
19819631 2010
421
Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum. 38
19836896 2010
422
Detection and identification of Ehrlichia species in blood by use of PCR and electrospray ionization mass spectrometry. 38
19955274 2010
423
Metapopulation models in tick-borne disease transmission modelling. 38
20632529 2010
424
Anaplasma phagocytophilum in horses and ticks: a preliminary survey of Central Italy. 38
18805584 2010
425
Molecular characterization of antibody epitopes of Ehrlichia chaffeensis ankyrin protein 200 and tandem repeat protein 47 and evaluation of synthetic immunodeterminants for serodiagnosis of human monocytotropic ehrlichiosis. 38
19955322 2010
426
Molecular and clinical evidence of Ehrlichia chaffeensis infection in Cameroonian patients with undifferentiated febrile illness. 38
20030996 2009
427
Persistent infection contributes to heterologous protective immunity against fatal ehrlichiosis. 38
19805532 2009
428
[Ehrlichiosis/Anaplasmosis]. 38
20077398 2009
429
Results from a mathematical model for human monocytic ehrlichiosis. 38
20584161 2009
430
An acute severe ehrlichiosis in a dog experimentally infected with a new virulent strain of Ehrlichia canis. 38
19548986 2009
431
Canine ehrlichiosis in the Ivory Coast and Gabon: alteration of biochemical blood parameters based on Ehrlichia canis serology. 38
19793128 2009
432
Ehrlichia chaffeensis infections in Drosophila melanogaster. 38
19687202 2009
433
Antigen display, T-cell activation, and immune evasion during acute and chronic ehrlichiosis. 38
19635826 2009
434
Molecular diagnosis of Anaplasmataceae organisms in dogs with clinical and microscopical signs of ehrlichiosis. 38
20040204 2009
435
Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. 38
20178476 2009
436
Evaluation of a serum-based PCR assay for the diagnosis of canine monocytic ehrlichiosis. 38
19419823 2009
437
A first case of ehrlichiosis in a horse in Poland. 38
19813450 2009
438
Diminished hematopoietic activity associated with alterations in innate and adaptive immunity in a mouse model of human monocytic ehrlichiosis. 38
19451243 2009
439
Anaplasmosis and ehrlichiosis - Maine, 2008. 38
19779398 2009
440
Detection of Ehrlichia canis by polymerase chain reaction in dogs from Portugal. 38
18682335 2009
441
All eyes on ehrlichiosis. 38
19633508 2009
442
Emerging arthropod-borne diseases of companion animals in Europe. 38
19403239 2009
443
Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. 38
19681699 2009
444
Diagnosis and treatment of tick infestation and tick-borne diseases with cutaneous manifestations. 38
19580576 2009
445
Tick-borne febrile illnesses lacking specific symptoms. 38
19753926 2009
446
[Ehrlichia canis in dogs attended in a veterinary hospital from Botucatu, São Paulo State, Brazil]. 38
19772777 2009
447
Clinical outcomes of solid organ transplant recipients with ehrlichiosis. 38
19228344 2009
448
Comparison of two clinic-based immunoassays with the immunofluorescence antibody test for the field diagnosis of canine monocytic ehrlichiosis. 38
19621766 2009
449
Promoter analysis of macrophage- and tick cell-specific differentially expressed Ehrlichia chaffeensis p28-Omp genes. 38
19454021 2009
450
A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi as an antigen for delayed-type hypersensitivity assays and serodiagnosis of canine visceral leishmaniasis. 38
19269098 2009
451
Clinical relevance of annual screening using a commercial enzyme-linked immunosorbent assay (SNAP 3Dx) for canine ehrlichiosis. 38
19411647 2009
452
Longitudinal quantification of Ehrlichia canis in experimental infection with comparison to natural infection. 38
19128893 2009
453
Type IV secretion system of Anaplasma phagocytophilum and Ehrlichia chaffeensis. 38
19538269 2009
454
[Detection of tick and tick-borne pathogen in some ports of Inner Mongolia]. 38
19731529 2009
455
Tick control methods used by resource-limited farmers and the effect of ticks on cattle in rural areas of the Eastern Cape Province, South Africa. 38
18704741 2009
456
Serological survey of Ehrlichia canis in stray dogs from Yucatan, Mexico, using two different diagnostic tests. 38
18945189 2009
457
Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemic. 38
19129471 2009
458
Clinical, serological, and molecular evidence of ehrlichiosis and anaplasmosis in dogs in Tunisia. 38
19018569 2009
459
Short report: serologic evidence of human ehrlichiosis in Peru. 38
19190221 2009
460
Liver transcriptome profiles associated with strain-specific Ehrlichia chaffeensis-induced hepatitis in SCID mice. 38
19001077 2009
461
Four VirB6 paralogs and VirB9 are expressed and interact in Ehrlichia chaffeensis-containing vacuoles. 38
18952796 2009
462
Ectoparasites of rodents captured in bandar abbas, southern iran. 38
22808381 2009
463
Other tick-borne diseases in Europe. 38
19367099 2009
464
What should one do in case of a tick bite? 38
19367100 2009
465
Human ehrlichiosis: a case study. 38
19354021 2009
466
Molecular characterization of Ehrlichia interactions with tick cells and macrophages. 38
19273271 2009
467
Molecular evaluation of the incidence of Ehrlichia canis, Anaplasma platys and Babesia spp. in dogs from Ribeirão Preto, Brazil. 38
17920967 2009
468
Tick-borne ehrlichiosis infection in human beings. 38
19248653 2008
469
Surveys of rodent-borne disease in Thailand with a focus on scrub typhus assessment. 38
21396076 2008
470
Defining the immune response to Ehrlichia species using murine models. 38
19028013 2008
471
Pathologic evidence of ehrlichiosis in calves inoculated with Ehrlichia chaffeensis. 38
19120184 2008
472
Immunophenotype of dogs with subclinical ehrlichiosis. 38
19120187 2008
473
Antibiotic clearance of Ehrlichia canis from dogs infected by intravenous inoculation of carrier blood. 38
19120226 2008
474
Comparison between different polymerase chain reaction methods for the diagnosis of Ehrlichia canis infection. 38
19120188 2008
475
[Detection of co-infection with Lyme spirochetes and Spotted fever group rickettsiae in a group of Haemaphysalis longicornis]. 38
19173967 2008
476
Host surveys, ixodid tick biology and transmission scenarios as related to the tick-borne pathogen, Ehrlichia canis. 38
18963493 2008
477
Total, membrane, and immunogenic proteomes of macrophage- and tick cell-derived Ehrlichia chaffeensis evaluated by liquid chromatography-tandem mass spectrometry and MALDI-TOF methods. 38
18710870 2008
478
Anaplasma phagocytophilum transmitted through blood transfusion--Minnesota, 2007. 38
18946461 2008
479
[Seroepidemiological evidence of human exposure to Anaplasma sp in Santiago, Chile]. 38
18949148 2008
480
Retrospective clinical and molecular analysis of conditioned laboratory dogs (Canis familiaris) with serologic reactions to Ehrlichia canis, Borrelia burgdorferi, and Rickettsia rickettsii. 38
18947166 2008
481
Serum cardiac troponin I concentration in dogs with ehrlichiosis. 38
18638021 2008
482
[Cattle farmers' perception of the nuisances caused by insects and ticks to cattle in the Canton Jura]. 38
18925555 2008
483
Cultivation and molecular identification of Ehrlichia canis and Ehrlichia chaffeensis from a naturally co-infected dog in Venezuela. 38
18761516 2008
484
Proteomic analysis of and immune responses to Ehrlichia chaffeensis lipoproteins. 38
18490460 2008
485
Larval tick infestation: a case report and review of tick-borne disease. 38
18712023 2008
486
Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease. 38
18646588 2008
487
Molecular characterization of Thai Ehrlichia canis and Anaplasma platys strains detected in dogs. 38
17643354 2008
488
In vitro isolation and molecular characterization of an Ehrlichia canis strain from São Paulo, Brazil. 38
24031251 2008
489
Ehrlichia chaffeensis infection in dogs in South Korea. 38
18399775 2008
490
Isolation and molecular detection of Ehrlichia from vertebrate animals. 38
18770538 2008
491
Prognostic indicators for canine monocytic ehrlichiosis. 38
18289794 2008
492
Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge. 38
18285501 2008
493
Laboratory maintenance of Ehrlichia chaffeensis and Ehrlichia canis and recovery of organisms for molecular biology and proteomics studies. 38
18770537 2008
494
Application of 10% imidacloprid/50% permethrin to prevent Ehrlichia canis exposure in dogs under natural conditions. 38
18359166 2008
495
A retrospective study of 61 cases of spontaneous canine epistaxis (1998 to 2001). 38
17850275 2008
496
Geographic distribution and genetic diversity of the Ehrlichia sp. from Panola Mountain in Amblyomma americanum. 38
18433500 2008
497
Enhanced spatial models for predicting the geographic distributions of tick-borne pathogens. 38
18412972 2008
498
The first report of human illness associated with the Panola Mountain Ehrlichia species: a case report. 38
18447934 2008
499
A variable-length PCR target protein of Ehrlichia chaffeensis contains major species-specific antibody epitopes in acidic serine-rich tandem repeats. 38
18212082 2008
500
Natural and experimental infection of white-tailed deer (Odocoileus virginianus) from the United States with an Ehrlichia sp. closely related to Ehrlichia ruminantium. 38
18436670 2008
501
Predicting the emergence of tick-borne infections based on climatic changes in Korea. 38
18429692 2008
502
Ehrlichia ewingii infection delays spontaneous neutrophil apoptosis through stabilization of mitochondria. 38
18462160 2008
503
Regulatory roles of CD1d-restricted NKT cells in the induction of toxic shock-like syndrome in an animal model of fatal ehrlichiosis. 38
18212072 2008
504
The importance of early treatment with doxycycline in human ehrlichiosis. 38
18344803 2008
505
Use of Drosophila S2 cells as a model for studying Ehrlichia chaffeensis infections. 38
18245255 2008
506
Assessment of intraspecific mtDNA variability of European Ixodes ricinus sensu stricto (Acari: Ixodidae). 38
18206426 2008
507
Acute infection with human monocytic ehrlichiosis: the tip of the iceberg? 38
18364633 2008
508
Detection of Ehrlichia canis by PCR in different tissues obtained during necropsy from dogs surveyed for naturally occurring canine monocytic ehrlichiosis. 38
17368942 2008
509
A study of cross-reactivity in serum samples from dogs positive for Leishmania sp., Babesia canis and Ehrlichia canis in enzyme-linked immunosorbent assay and indirect fluorescent antibody test. 38
18554433 2008
510
Human granulocytic ehrlichiosis complicating early pregnancy. 38
18509484 2008
511
Imported non-endemic, arthropod-borne and parasitic infectious diseases in Austrian dogs. 38
19066775 2008
512
Fever of unknown origin due to rickettsioses. 38
18061086 2007
513
Experimental infection of dairy calves with Ehrlichia chaffeensis. 38
18033836 2007
514
Outbreak of canine monocytic ehrlichiosis in Saudi Arabia. 38
18041697 2007
515
Sequence and phylogenetic analysis of the 16S rRNA gene of Ehrlichia canis strains in dogs with clinical monocytic ehrlichiosis. 38
17624694 2007
516
Remission of cunical signs of adult-onset generalized demodicosis after treatment for concurrent babesiosis and/or granulocytic ehrlichiosis in dogs. 38
18225424 2007
517
Sero-prevalence and risk indicators for canine ehrlichiosis in three rural areas of Brazil. 38
17204439 2007
518
Development of a sensitive and specific indirect enzyme-linked immunosorbent assay based on a baculovirus recombinant antigen for detection of specific antibodies against Ehrlichia canis. 38
17998551 2007
519
Doxycycline clearance of experimentally induced chronic Ehrlichia canis infection in dogs. 38
18196732 2007
520
CD4 T-cell epitopes associated with protective immunity induced following vaccination of mice with an ehrlichial variable outer membrane protein. 38
17698576 2007
521
Relative importance of T-cell subsets in monocytotropic ehrlichiosis: a novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis. 38
17562770 2007
522
Human granulocytic anaplasmosis during pregnancy: case series and literature review. 38
17682993 2007
523
Anaplasma platys in dogs, Chile. 38
18252119 2007
524
Tick acquisition of Ehrlichia canis from dogs treated with doxycycline hyclate. 38
17606682 2007
525
Resolution of chronic hepatitis C following parasitosis. 38
17696260 2007
526
Verses, viruses, and the vulnerability of the blood supply in industrialized countries. 38
17596828 2007
527
Human ehrlichiosis: clinical and ecological challenges. 38
17713299 2007
528
Ehrlichiosis: making the diagnosis in the acute setting. 38
17713310 2007
529
Molecular evidence of a new strain of Ehrlichia canis from South America. 38
17596368 2007
530
Virulence potential of Ehrlichia chaffeensis strains of distinct genome sequences. 38
17438035 2007
531
Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. 38
17582569 2007
532
Transmission of Ehrlichia chaffeensis from lone star ticks (Amblyomma americanum) to white-tailed deer (Odocoileus virginianus). 38
17699076 2007
533
Human monocytic ehrlichiosis in children. 38
17529862 2007
534
Human ehrlichiosis in transplant recipients. 38
17511689 2007
535
Ocular manifestations of natural canine monocytic ehrlichiosis (Ehrlichia canis): a retrospective study of 90 cases. 38
17445073 2007
536
B-cell lymphoma in a dog with ehrlichiosis (Ehrlichia canis) and systemic histoplasmosis (Histoplasma capsulatum). 38
17436907 2007
537
Lyme disease followed by human granulocytic anaplasmosis in a kidney transplant recipient. 38
17313478 2007
538
Enzyme-linked immunosorbent assay with conserved immunoreactive glycoproteins gp36 and gp19 has enhanced sensitivity and provides species-specific immunodiagnosis of Ehrlichia canis infection. 38
17151186 2007
539
Habitat factors influencing distributions of Anaplasma phagocytophilum and Ehrlichia chaffeensis in the Mississippi Alluvial Valley. 38
18047394 2007
540
Ecological havoc, the rise of white-tailed deer, and the emergence of Amblyomma americanum-associated zoonoses in the United States. 38
17848069 2007
541
Death of a horse infected experimentally with Anaplasma phagocytophilum. 38
17259454 2007
542
Serosurvey for CPV-2, distemper virus, ehrlichiosis and leishmaniosis in free-ranging dogs in Italy. 38
17237459 2007
543
Differential clearance and immune responses to tick cell-derived versus macrophage culture-derived Ehrlichia chaffeensis in mice. 38
17060466 2007
544
Surveillance for zoonotic vector-borne infections using sick dogs from southeastern Brazil. 38
18021025 2007
545
Ehrlichia species in Rhipicephalus sanguineus ticks in Cameroon. 38
17627442 2007
546
[Human anaplasmosis (ehrlichiosis)]. 38
17217096 2006
547
Platelet aggregation and haemostatic response in dogs naturally co-infected by Leishmania infantum and Ehrlichia canis. 38
17105577 2006
548
A retrospective study of aplastic pancytopenia in the dog: 9 cases (1996-2003). 38
17123247 2006
549
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. 38
17029130 2006
550
Toxoplasma gondii genotyping in a dog co-infected with distemper virus and ehrlichiosis rickettsia. 38
17221136 2006
551
Endocrine dysfunction in chronic severe ehrlichiosis with or without babesiosis in dogs. 38
17139541 2006
552
Ehrlichiosis as a near-fatal cause of postoperative fever after bilateral total knee arthroplasty. 38
17080650 2006
553
Human infection with Ehrlichia canis accompanied by clinical signs in Venezuela. 38
17114689 2006
554
Human monocytic ehrlichiosis and human granulocytic anaplasmosis in the United States, 2001-2002. 38
17114690 2006
555
Molecular diagnosis of granulocytic anaplasmosis and infectious cyclic thrombocytopenia by PCR-RFLP. 38
17135540 2006
556
Two cases of human granulocytic ehrlichiosis in Sardinia, Italy confirmed by PCR. 38
17114774 2006
557
New findings on anaplasmosis caused by infection with Anaplasma phagocytophilum. 38
17135539 2006
558
Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. 38
17114714 2006
559
Cytokine gene expression by peripheral blood leukocytes in dogs experimentally infected with a new virulent strain of Ehrlichia canis. 38
17114759 2006
560
Fatal recall responses mediated by CD8 T cells during intracellular bacterial challenge infection. 38
16982903 2006
561
Surveys on seroprevalence of canine monocytic ehrlichiosis among dogs living in the Ivory Coast and Gabon and evaluation of a quick commercial test kit dot-ELISA. 38
17114755 2006
562
Biochemical activities of three pairs of Ehrlichia chaffeensis two-component regulatory system proteins involved in inhibition of lysosomal fusion. 38
16926392 2006
563
Bone marrow mastocytosis in dogs with myelosuppressive monocytic ehrlichiosis (Ehrlichia canis): a retrospective study. 38
16967415 2006
564
Seroepidemiology of canine babesiosis and ehrlichiosis in a hospital population. 38
16647817 2006
565
Unique macrophage and tick cell-specific protein expression from the p28/p30-outer membrane protein multigene locus in Ehrlichia chaffeensis and Ehrlichia canis. 38
16922866 2006
566
Intra-leukocyte expression of two-component systems in Ehrlichia chaffeensis and Anaplasma phagocytophilum and effects of the histidine kinase inhibitor closantel. 38
16882029 2006
567
An intradermal environment promotes a protective type-1 response against lethal systemic monocytotropic ehrlichial infection. 38
16861674 2006
568
Lymph node hemophagocytosis in rickettsial diseases: a pathogenetic role for CD8 T lymphocytes in human monocytic ehrlichiosis (HME)? 38
16859547 2006
569
Failure of imidocarb dipropionate to clear experimentally induced Ehrlichia canis infection in dogs. 38
16955806 2006
570
Dog tick-borne diseases in Sicily. 38
16881419 2006
571
The genome of the obligately intracellular bacterium Ehrlichia canis reveals themes of complex membrane structure and immune evasion strategies. 38
16707693 2006
572
Detection of Ehrlichia chaffeensis in Brazilian marsh deer (Blastocerus dichotomus). 38
16621285 2006
573
Tick-transmitted diseases in dogs: clinicopathological findings. 38
16881415 2006
574
Ehrlichia infection of the central nervous system. 38
16569376 2006
575
Genetic characterization of Anaplasma (Ehrlichia) platys in dogs in Spain. 38
16629989 2006
576
[Human ehrlichiosis]. 38
16683411 2006
577
Clinical signs and clinicopathologic abnormalities in dogs with clinical spirocercosis: 39 cases (1996-2004). 38
16579785 2006
578
Canine visceral leishmaniosis: a comparative analysis of the EIE-leishmaniose-visceral-canina-Bio-Manguinhos and the IFI-leishmaniose-visceral-canina-Bio-Manguinhos kits. 38
16446034 2006
579
Detection of Anaplasma phagocytophilum and Babesia odocoilei DNA in Ixodes scapularis (Acari: Ixodidae) collected in Indiana. 38
16619631 2006
580
Platelet aggregation studies in acute experimental canine ehrlichiosis. 38
16511794 2006
581
Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. 38
16572105 2006
582
Role of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 in the pathogenesis of severe murine monocytotropic ehrlichiosis: increased resistance of TNF receptor p55- and p75-deficient mice to fatal ehrlichial infection. 38
16495559 2006
583
[Bacterial zoonoses: emerging concepts]. 38
17140097 2006
584
Comparative genomics of emerging human ehrlichiosis agents. 38
16482227 2006
585
More about human monocytotropic ehrlichiosis in Brazil: serological evidence of nine new cases. 38
16767308 2006
586
Reduced number of interleukin-12 secreting cells in patients with Lyme borreliosis previously exposed to Anaplasma phagocytophilum. 38
16412057 2006
587
Novel genetic variants of Anaplasma phagocytophilum, Anaplasma bovis, Anaplasma centrale, and a novel Ehrlichia sp. in wild deer and ticks on two major islands in Japan. 38
16461655 2006
588
Human monocytic ehrlichiosis in a renal transplant patient. 38
16857619 2006
589
Anaplasma phagocytophilum in Ixodes ricinus ticks and human granulocytic anaplasmosis seroprevalence among forestry rangers in Białystok region. 38
17357327 2006
590
[Global warming, ticks, and ehrlichiosis]. 38
17137185 2006
591
Ehrlichiosis. 38
16395107 2006
592
Experimental Ehrlichia canis infection in the dog does not cause immunosuppression. 38
16169601 2006
593
Differentially expressed and secreted major immunoreactive protein orthologs of Ehrlichia canis and E. chaffeensis elicit early antibody responses to epitopes on glycosylated tandem repeats. 38
16369028 2006
594
Old and new human rickettsiosis in Minas Gerais state, Brazil. 38
16481542 2005
595
Balancing protective immunity and immunopathology: a unifying model of monocytotropic ehrlichiosis. 38
16481546 2005
596
Susceptibility and resistance to monocytic ehrlichiosis in the mouse. 38
16481547 2005
597
Early transcriptional response of human neutrophils to Anaplasma phagocytophilum infection. 38
16299303 2005
598
Anaplasma and Ehrlichia infection. 38
16481544 2005
599
Essential role for humoral immunity during Ehrlichia infection in immunocompetent mice. 38
16299294 2005
600
[Prevalence of antibodies against Anaplasma phagocytophilum, Babesia microti i Borrelia burgdorferi in adults in North-Eastern Poland]. 38
16521416 2005
601
Overcoming barriers to the transformation of the genus Ehrlichia. 38
16481548 2005
602
A real-time combined polymerase chain reaction assay for the rapid detection and differentiation of Anaplasma phagocytophilum, Ehrlichia chaffeensis, and Ehrlichia ewingii. 38
16263231 2005
603
Cytokine responses in dogs infected with Ehrlichia canis Oklahoma strain. 38
16481554 2005
604
Ocular signs of canine monocytic ehrlichiosis: a retrospective study in dogs from Barcelona, Spain. 38
16359361 2005
605
Images in emergency medicine. Human ehrlichiosis. 38
16271680 2005
606
Immune-mediated haemolytic anaemia and thrombocytopenia associated with Anaplasma phagocytophilum in a dog. 38
16300116 2005
607
Ehrlichial infection in Cameroonian canines by Ehrlichia canis and Ehrlichia ewingii. 38
16181750 2005
608
Detection of antibodies to Borrelia burgdorferi in naturally infected horses in the USA by enzyme-linked immunosorbent assay using whole-cell and recombinant antigens. 38
15924926 2005
609
Epidemiology of heartworm: what is happening in South America and Mexico? 38
16198820 2005
610
Acute granulocytic ehrlichiosis in a rottweiler. 38
16141184 2005
611
Evaluation of neutrophil oxidative metabolism in canine monocytic ehrlichiosis. 38
16134067 2005
612
Feline leishmaniasis and ehrlichiosis: serological investigation in Abruzzo region. 38
16244984 2005
613
Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002. 38
16103612 2005
614
Laboratory Maintenance of Anaplasma phagocytophilum. 38
18770564 2005
615
Molecular detection and characterization of Ehrlichia canis from dogs in Turkey. 38
16048040 2005
616
[Ehrlichiosis and human anaplasmosis]. 38
15970171 2005
617
Clinical, epidemiologic, and environmental surveillance for ehrlichiosis and anaplasmosis in an endemic area of northern California. 38
16007950 2005
618
Prevention of Lyme borreliosis. 38
16053192 2005
619
Tick-borne disease. 38
15999870 2005
620
A preliminary study to evaluate the immune responses induced by immunization of dogs with inactivated Ehrlichia canis organisms. 38
16137129 2005
621
Microscopic and clinical evidence for Anaplasma (Ehrlichia) phagocytophilum infection in Italian cats. 38
15951500 2005
622
Spatial analysis of the distribution of Ehrlichia chaffeensis, causative agent of human monocytotropic ehrlichiosis, across a multi-state region. 38
15964974 2005
623
Diarrhea caused by primarily non-gastrointestinal infections. 38
16265204 2005
624
Validation of chemoprevention of canine monocytic ehrlichiosis with doxycycline. 38
15863288 2005
625
Anti-Hepatozoon canis serum antibodies and gamonts in naturally-occurring canine monocytic ehrlichiosis. 38
15845277 2005
626
Presence of Borrelia burgdorferi (Spirochaetales: Spirochaetaceae) in southern Kettle Moraine State Forest, Wisconsin, and characterization of strain W97F51. 38
15962800 2005
627
Tick- and flea-borne rickettsial emerging zoonoses. 38
15845235 2005
628
Exotic diseases of dogs and cats at risk of importation to Ireland. 38
21851670 2005
629
Multiplex detection of Ehrlichia and Anaplasma species pathogens in peripheral blood by real-time reverse transcriptase-polymerase chain reaction. 38
15858156 2005
630
Seroepidemiology of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in wild mice captured in northern Turkey. 38
15816159 2005
631
Acute clinical, hematologic, serologic, and polymerase chain reaction findings in horses experimentally infected with a European strain of Anaplasma phagocytophilum. 38
15822569 2005
632
Detection and identification of Ehrlichia spp. in ticks collected in Tunisia and Morocco. 38
15750072 2005
633
Sequence analysis of the msp4 gene of Anaplasma phagocytophilum strains. 38
15750101 2005
634
Concomitant tickborne encephalitis and human granulocytic ehrlichiosis. 38
15757574 2005
635
Identification of Anaplasma phagocytophilum on the basis of a fragment of the 16S rDNA gene. 38
19058544 2005
636
West Nile viral encephalitis mimicking hepatic encephalopathy. 38
15647737 2005
637
Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein. 38
15618156 2005
638
Tick-borne infections in children: epidemiology, clinical manifestations, and optimal management strategies. 38
15977962 2005
639
[Hepatitis caused by tick-borne meningoencephalitis virus (TBEV)--a rare clinical manifestation outside the central nervous system involvement]. 38
16334744 2005
640
Five decades of tick-man interaction in Denmark--an analysis. 38
15777006 2005
641
[Ehrlichiosis]. 38
16786789 2005
642
Primary and secondary infection with Ehrlichia chaffeensis in white-tailed deer (Odocoileus virginianus). 38
15815149 2005
643
Ehrlichia under our noses and no one notices. 38
16358425 2005
644
Prevalence of Ehrlichia canis infection in thrombocytopenic dogs from Rio de Janeiro, Brazil. 38
15732017 2005
645
Risk of tick-borne bacterial diseases among workers of Roztocze National Park (south-eastern Poland). 38
16028877 2005
646
Ehrlichia chaffeensis expresses macrophage- and tick cell-specific 28-kilodalton outer membrane proteins. 38
15618143 2005
647
Seroprevalence of tick-borne infections in forestry rangers from northeastern Italy. 38
15606631 2004
648
Ectoparasites and other epifaunistic arthropods of sympatric cotton mice and golden mice: comparisons and implications for vector-borne zoonotic diseases. 38
15715219 2004
649
Human monocytic ehrlichiosis. 38
15536115 2004
650
[Morphologic identification of Ehrlichia sp. in the platelets of patients infected with the human immunodeficiency virus in Venezuela]. 38
15729984 2004
651
JAMA patient page. Ehrlichiosis. 38
15536118 2004
652
Detection of Ehrlichia chaffeensis in adult and nymphal Amblyomma americanum (Acari: Ixodidae) ticks from Long Island, New York. 38
15605650 2004
653
Comparison of simultaneous splenic sample PCR with blood sample PCR for diagnosis and treatment of experimental Ehrlichia canis infection. 38
15504892 2004
654
[Ehrlichia and Babesia infections in dogs in The Netherlands]. 38
15622893 2004
655
Assessment of feline ehrlichiosis in central Spain using serology and a polymerase chain reaction technique. 38
15604476 2004
656
Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model. 38
15331423 2004
657
[Tick-borne infections]. 38
15473378 2004
658
High seroprevalence of granulocytic ehrlichiosis distinguishes sheep that were the source of an alimentary epidemic of tick-borne encephalitis. 38
15515879 2004
659
Diffuse cutaneous candidiasis in a dog. Diagnosis by PCR-REA. 38
15709788 2004
660
Neutrophil NADPH oxidase is reduced at the Anaplasma phagocytophilum phagosome. 38
15322037 2004
661
Tick-borne rickettsial diseases: emerging risks in Europe. 38
15225980 2004
662
The role of wildlife in emerging and re-emerging zoonoses. 38
15702716 2004
663
Naturally occurring tularemia in a dog. 38
15344361 2004
664
Molecular diagnosis of human granulocytic anaplasmosis. 38
15225103 2004
665
Human ehrlichioses in Brazil: first suspect cases. 38
15476059 2004
666
[Tick borne zoonosis: selected clinical and diagnostic aspects]. 38
15305697 2004
667
[Ixodes ricinus, transmitted diseases and reservoirs]. 38
15305699 2004
668
Production of IFN-gamma by CD4 T cells is essential for resolving ehrlichia infection. 38
15153508 2004
669
Anaplasma phagocytophilum: an emerging tick-borne pathogen in Hungary and Central Eastern Europe. 38
15228721 2004
670
Generalized Microsporum canis dermatophytosis in six Yorkshire terrier dogs. 38
15214955 2004
671
Anaplasma phagocytophilum ligation to toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-kappa B nuclear translocation. 38
15122530 2004
672
In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis. 38
15113857 2004
673
Infection and blood transfusion: a guide to donor screening. 38
15179926 2004
674
Chronic canine ehrlichiosis (Ehrlichia canis): a retrospective study of 19 natural cases. 38
15131097 2004
675
Characteristic peripheral blood findings in human ehrlichiosis. 38
14976527 2004
676
[Tick-borne human pathogenic microorganisms found in Europe and those considered nonpathogenic. Part II: Bacteria, parasites and mixed infections]. 38
15205761 2004
677
Human granulocytic ehrlichiosis in Europe. 38
15146982 2004
678
Human granulocytic ehrlichiosis: "out of the Lyme light". 38
15095825 2004
679
Detection of Anaplasma phagocytophilum in animals by real-time polymerase chain reaction. 38
15233638 2004
680
Use of recombinant antigens of Borrelia burgdorferi and Anaplasma phagocytophilum in enzyme-linked immunosorbent assays to detect antibodies in white-tailed deer. 38
15362824 2004
681
[Human granulocytic ehrlichiosis in Europe]. 38
15617351 2004
682
Detection of pathogenic Ehrlichia in ticks collected at acquisition sites of human ehrlichiosis in Missouri. 38
15119113 2004
683
[Emergence of tick-borne diseases in temperate countries]. 38
15047466 2004
684
Ehrlichia chaffeensis downregulates surface Toll-like receptors 2/4, CD14 and transcription factors PU.1 and inhibits lipopolysaccharide activation of NF-kappa B, ERK 1/2 and p38 MAPK in host monocytes. 38
14706103 2004
685
Mechanisms of immunity to Ehrlichia muris: a model of monocytotropic ehrlichiosis. 38
14742542 2004
686
Overproduction of TNF-alpha by CD8+ type 1 cells and down-regulation of IFN-gamma production by CD4+ Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis. 38
14734762 2004
687
[Detection of anti-Ehrlichia antibodies and direct demonstration of Ehrlichia nucleic acid using the polymerase chain reaction (PCR) in patients in the Czech Republic]. 38
15100980 2004
688
Experimental acute canine monocytic ehrlichiosis: clinicopathological and immunopathological findings. 38
15036578 2004
689
Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice. 38
14688093 2004
690
Evaluation of immunocompetent and immunocompromised mice (Mus musculus) for infection with Ehrlichia chaffeensis and transmission to Amblyomma americanum ticks. 38
15671738 2004
691
Treatment and prevention of rickettsial and ehrlichial infections. 38
15571498 2004
692
Discovering new pathogens: culture-resistant bacteria. 38
15148425 2004
693
[Epidemiological evaluation of a possible outbreak in and nearby Tokat province]. 38
15293900 2004
694
Comparison of patients fulfilling criteria for confirmed and probable human granulocytic ehrlichiosis. 38
15764167 2004
695
[Human granulocytic ehrlichiosis co-incident with Lyme borreliosis in pregnant woman--a case study]. 38
15517809 2004
696
Incidence and prevalence of infection with Anaplasma phagocytophilum. Prospective study in healthy individuals exposed to ticks. 38
15236514 2004
697
[Advances in comparative pathology: some zoonoses threatening man]. 38
15656242 2004
698
Human anaplasmosis in north-eastern Poland: seroprevalence in humans and prevalence in Ixodes ricinus ticks. 38
15236505 2004
699
[Ehrlichiosis--a disease rarely recognized in Poland]. 38
15765762 2004
700
On molecular taxonomy: what is in a name? 38
15176735 2004
701
[Prevalence of antibodies to Anaplasma phagocytophilum and Borrelia burgdorferi in forestry workers from the Lublin region]. 38
16859027 2004
702
[Participation of Ixodes ricinus developmental stages in transmission of Anaplasma (Ehrlichia) phagocytophila]. 38
16865969 2004
703
A serosurvey of Hepatozoon canis and Ehrlichia canis antibodies in wild red foxes (Vulpes vulpes) from Israel. 38
15036573 2004
704
The relationship between the degree of thrombocytopenia and infection with Ehrlichia canis in an endemic area. 38
15099511 2004
705
Characterization of Ehrlichia species from Ixodes ovatus ticks at the foot of Mt. Fuji, Japan. 38
15502406 2004
706
Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen. 38
17060980 2004
707
Attempted experimental infection of domestic goats with Ehrlichia chaffeensis. 38
15228813 2004
708
Bacterial responses to neutrophil phagocytosis. 38
14676620 2004
709
Emerging tick-borne infections: rediscovered and better characterized, or truly 'new' ? 38
15940821 2004
710
[Anaplasma phagocytophila and protozoans of Babesia genus in dogs from endemic areas of Lyme disease in north-western Poland]. 38
16865968 2004
711
Causes of febrile illnesses after a tick bite in Slovenian children. 38
14688569 2003
712
Divergent interactions of Ehrlichia chaffeensis- and Anaplasma phagocytophilum-infected leukocytes with endothelial cell barriers. 38
14638757 2003
713
Acarological risk of exposure to agents of tick-borne zoonoses in the first recognized Italian focus of Lyme borreliosis. 38
14959782 2003
714
Human monocytotropic ehrlichiosis, Missouri. 38
14720399 2003
715
Ehrlichiosis and related infections. 38
14690204 2003
716
Molecular methods for ehrlichiosis and Lyme disease. 38
14711096 2003
717
Ehrlichiosis in anemic, thrombocytopenic, or tick-infested dogs from a hospital population in South Brazil. 38
14637030 2003
718
Experimental Ehrlichia chaffeensis infection in beagles. 38
14532348 2003
719
Human granulocytic ehrlichiosis in Estonia. 38
14725264 2003
720
Human granulocytic ehrlichiosis presenting as acute abdomen in an adult. 38
14583879 2003
721
Murine neutrophils require alpha1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum. 38
12869507 2003
722
Invasion and survival strategies of Anaplasma phagocytophilum. 38
14531890 2003
723
Detection of antibodies to Anaplasma phagocytophilum and Ehrlichia chaffeensis antigens in sera of Korean patients by western immunoblotting and indirect immunofluorescence assays. 38
14607867 2003
724
Obligatory intracellular parasitism by Ehrlichia chaffeensis and Anaplasma phagocytophilum involves caveolae and glycosylphosphatidylinositol-anchored proteins. 38
14531896 2003
725
Risk and prevention of transfusion-transmitted babesiosis and other tick-borne diseases. 38
14564169 2003
726
High diversity of ankA sequences of Anaplasma phagocytophilum among Ixodes ricinus ticks in Germany. 38
14605135 2003
727
Serologically detected "new" tick-borne zoonoses in eastern Croatia. 38
14515426 2003
728
Antigens and alternatives for control of Anaplasma marginale infection in cattle. 38
14557295 2003
729
L-selectin and E-selectin expressed on monocytes mediating Ehrlichia chaffeensis attachment onto host cells. 38
14592723 2003
730
Cat or dog ownership and seroprevalence of ehrlichiosis, Q fever, and cat-scratch disease. 38
14609477 2003
731
[Renal amyloidosis caused by Ehrlichia canis]. 38
14593934 2003
732
Predominance of Ehrlichia ewingii in Missouri dogs. 38
14532192 2003
733
Portal vein and aortic thromboses in a Siberian husky with ehrlichiosis and hypothyroidism. 38
14510331 2003
734
Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. 38
12965923 2003
735
Dermatoses from ticks. 38
12963900 2003
736
Structurally distinct requirements for binding of P-selectin glycoprotein ligand-1 and sialyl Lewis x to Anaplasma phagocytophilum and P-selectin. 38
12847092 2003
737
Ehrlichia chaffeensis infections among HIV-infected patients in a human monocytic ehrlichiosis-endemic area. 38
14519250 2003
738
Reduced abundance of Ixodes scapularis (Acari: Ixodidae) and the tick parasitoid Ixodiphagus hookeri (Hymenoptera: Encyrtidae) with reduction of white-tailed deer. 38
14596277 2003
739
Successful treatment of human granulocytic ehrlichiosis in children using rifampin. 38
12949322 2003
740
Serological evidence for human granulocytic ehrlichiosis in Western Austria. 38
12938008 2003
741
Serotyping isolates of Anaplasma phagocytophilum by using monoclonal antibodies. 38
12965936 2003
742
Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. 38
12933880 2003
743
Thrombocytopaenia in canine babesiosis and its clinical usefulness. 38
15029948 2003
744
Human Granulocytic Ehrlichiosis in Belgium: an underestimated cause of disease. 38
12860146 2003
745
Enzootic transmission of Anaplasma bovis in Nantucket cottontail rabbits. 38
12904385 2003
746
Geographic information systems and spatial analysis of adult Ixodes scapularis (Acari: Ixodidae) in the Middle Atlantic region of the U.S.A. 38
14680128 2003
747
Ehrlichiosis and related infections. 38
12910747 2003
748
[Seroepidemiological studies of zoonotic infections in hunters in southeastern Austria--prevalences, risk factors, and preventive methods]. 38
12894685 2003
749
Detection of Borrelia burgdorferi, Ehrlichia chaffeensis, and Anaplasma phagocytophilum in ticks (Acari: Ixodidae) from a coastal region of California. 38
14680123 2003
750
Characterization of the major antigenic protein 2 of Ehrlichia canis and Ehrlichia chaffeensis and its application for serodiagnosis of ehrlichiosis. 38
12853379 2003
751
[Ehrlichiosis and anaplasmosis]. 38
12827744 2003
752
National surveillance for the human ehrlichioses in the United States, 1997-2001, and proposed methods for evaluation of data quality. 38
12860604 2003
753
Ehrlichiosis and rickettsiosis in a canine population of Northern Sardinia. 38
12860613 2003
754
Genetic diversity of bacterial agents detected in ticks removed from asymptomatic patients in northeastern Italy. 38
12860623 2003
755
Human granulocytic ehrlichiosis in Germany: evidence from serological studies, tick analyses, and a case of equine ehrlichiosis. 38
12860611 2003
756
Early induction and late abrogation of respiratory burst in A. phagocytophilum-infected neutrophils. 38
12860678 2003
757
Hepatic pathology in human monocytic ehrlichiosis. Ehrlichia chaffeensis infection. 38
12817434 2003
758
Human granulocytic ehrlichiosis in Slovenia. 38
12860640 2003
759
Enzootic transmission of the agent of human granulocytic ehrlichiosis among cottontail rabbits. 38
12887018 2003
760
Comparison of patients fulfilling criteria for confirmed and probable human granulocytic ehrlichiosis. 38
12860648 2003
761
Human granulocytic ehrlichiosis in Italy: first report on two confirmed cases. 38
12860650 2003
762
Equine ehrlichiosis in Italy. 38
12860637 2003
763
Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis. 38
12802782 2003
764
Ehrlichiae and ehrlichial diseases in china. 38
12860598 2003
765
Ehrlichia-like organism gene found in small mammals in the suburban district of Guangzhou of China. 38
12860609 2003
766
Laboratory aspects of tick-borne diseases: lyme, human granulocytic ehrlichiosis and babesiosis. 38
12764539 2003
767
[Fever after a tick bite: clinical manifestations and diagnosis of acute tick bite-associated infections in northeastern Switzerland]. 38
12736854 2003
768
Prevalence of Borrelia Burgdorferi sensu lato genomospecies and of the human granulocytic ehrlichiosis (HGE) agent in Ixodes ricinus ticks collected in the area of Monti Lepini, Italy. 38
12797900 2003
769
Prevalence of Anaplasma phagocytophila and Borrelia burgdorferi in Ixodes persulcatus ticks from northeastern China. 38
12812342 2003
770
A case of equine granulocytic ehrlichiosis provides molecular evidence for the presence of pathogenic anaplasma phagocytophilum (HGE agent) in Germany. 38
12740667 2003
771
Kinetics of antibody response to Ehrlichia canis immunoreactive proteins. 38
12704123 2003
772
Molecular characterization of Anaplasma phagocytophilum and Borrelia burgdorferi in Ixodes scapularis ticks from Pennsylvania. 38
12682147 2003
773
Cloning and characterization of an Ehrlichia canis gene encoding a protein localized to the morula membrane. 38
12654844 2003
774
First documented case of human granulocytic ehrlichiosis in Austria. 38
12778780 2003
775
Molecular identification of Ehrlichia ewingii infection in dogs: 15 cases (1997-2001). 38
12710774 2003
776
The hypervariable region of Anaplasma marginale major surface protein 2 (MSP2) contains multiple immunodominant CD4+ T lymphocyte epitopes that elicit variant-specific proliferative and IFN-gamma responses in MSP2 vaccinates. 38
12646645 2003
777
[Differential diagnosis of Lyme borreliosis]. 38
15104265 2003
778
Serologic evidence of infection with ehrlichiae and spotted fever group rickettsiae among residents of Gag Island, Indonesia. 38
12875301 2003
779
Roles of neutrophil beta 2 integrins in kinetics of bacteremia, extravasation, and tick acquisition of Anaplasma phagocytophila in mice. 38
12480703 2003
780
Ehrlichiosis optic neuritis. 38
12614774 2003
781
Evidence for modulated immune response to Anaplasma phagocytophila sensu lato in cats with FIV-induced immunosuppression. 38
12493491 2003
782
Molecular evidence of coinfection of Borrelia burgdorferi sensu lato, human granulocytic ehrlichiosis agent, and Babesia microti in ticks from northwestern Poland. 38
12659331 2003
783
Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum. 38
12574272 2003
784
Conservation of a gene conversion mechanism in two distantly related paralogues of Anaplasma marginale. 38
12535066 2003
785
[Ehrlichiosis]. 38
12722272 2003
786
Distribution of ehrlichiae in tissues as determined by in-situ hybridization. 38
12634096 2003
787
Assay of fipronil efficacy to prevent canine monocytic ehrlichiosis in endemic areas. 38
12581587 2003
788
Evaluation of cytology in the diagnosis of acute canine monocytic ehrlichiosis (Ehrlichia canis): a comparison between five methods. 38
12458168 2003
789
Transcriptional analysis of p30 major outer membrane protein genes of Ehrlichia canis in naturally infected ticks and sequence analysis of p30-10 of E canis from diverse geographic regions. 38
12574308 2003
790
[The first case of granulocytic ehrlichiosis in the Far East of the Russian Federation]. 38
12685241 2003
791
[Serologic evidence for human Ehrlichiosis in Chile]. 38
12643221 2003
792
Acute urticaria and angioedema due to ehrlichiosis. 38
14657642 2003
793
Ehrlichia chaffeensis: a prototypical emerging pathogen. 38
12525424 2003
794
Molecular heterogeneity of Ehrlichia chaffeensis isolates determined by sequence analysis of the 28-kilodalton outer membrane protein genes and other regions of the genome. 38
12496165 2003
795
[An abortive type of tick-borne meningoencephalitis]. 38
12879690 2003
796
Evidence of Babesia microti infection in multi-infected Ixodes persulcatus ticks in Russia. 38
14635819 2003
797
Canine granulocytic ehrlichiosis (CGE) in Italy. 38
12688128 2003
798
Simultaneous infection with Borrelia burgdorferi and human granulocytic ehrlichiosis. 38
12553302 2003
799
Polymerase chain reaction in detection of human granulocytic ehrlichiosis (HGE) agent DNA in Ixodes ricinus ticks. 38
15232900 2003
800
Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. 38
12499227 2003
801
Rickettsial, ehrlichial and Bartonella infections of the myocardium and pericardium. 38
12456377 2003
802
Canine ehrlichiosis. 38
14677903 2003
803
[Sero-epidemiological studies of zoonotic infections in hunters--comparative analysis with veterinarians, farmers, and abattoir workers]. 38
15508783 2003
804
Evaluation of a prototype Ehrlichia chaffeensis surveillance system using white-tailed deer (Odocoileus virginianus) as natural sentinels. 38
14733672 2003
805
Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. 38
12471136 2002
806
Transmission of Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in horses using experimentally infected ticks (Ixodes scapularis). 38
12485358 2002
807
Human granulocytic ehrlichiosis in Europe. 38
12519349 2002
808
Avian reservoirs of the agent of human granulocytic ehrlichiosis? 38
12498679 2002
809
[Ehrlichia chaffeensis antibodies prevalence among patients bitten by ticks]. 38
12666441 2002
810
Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors. 38
12473139 2002
811
Ehrlichiosis in cats. 38
12465758 2002
812
Differential serological testing by simultaneous indirect immunofluorescent antibody test in canine leishmaniosis and ehrlichiosis. 38
12423931 2002
813
[Detection of natural foci of babesiosis and granulocytic ehrlichiosis in Russia]. 38
12506622 2002
814
Leishmania major-like antigen for specific and sensitive serodiagnosis of human and canine visceral leishmaniasis. 38
12414775 2002
815
Human monocytic ehrlichiosis presenting as acute appendicitis during pregnancy. 38
12384854 2002
816
[Comparison of extraction methods for detection of Ehrlichia DNA in whole blood using PCR]. 38
12532899 2002
817
Molecular evidence supporting Ehrlichia canis-like infection in cats. 38
12465759 2002
818
Ehrlichiosis in children. 38
12491230 2002
819
PCR detection of Borrelia burgdorferi sensu lato, tick-borne encephalitis virus, and the human granulocytic ehrlichiosis agent in Ixodes persulcatus ticks from Western Siberia, Russia. 38
12354885 2002
820
Activation of a p44 pseudogene in Anaplasma phagocytophila by bacterial RNA splicing: a novel mechanism for post-transcriptional regulation of a multigene family encoding immunodominant major outer membrane proteins. 38
12366837 2002
821
Treatment of tick-borne diseases. 38
12243610 2002
822
Molecular and microscopical evidence of Ehrlichia spp. and Borrelia burgdorferi sensu lato in patients, animals and ticks in the Czech Republic. 38
12437223 2002
823
The mouse as a model for investigation of human granulocytic ehrlichiosis: current knowledge and future directions. 38
12405632 2002
824
[Tick-borne neurological diseases]. 38
12407309 2002
825
Cutaneous lesions in dogs with Dirofilaria (Nochtiella) repens infestation and concurrent tick-borne transmitted diseases. 38
12358611 2002
826
Differential expression of the p44 gene family in the agent of human granulocytic ehrlichiosis. 38
12183586 2002
827
Spatial analysis of human granulocytic ehrlichiosis near Lyme, Connecticut. 38
12194771 2002
828
Cytokine gene expression by peripheral blood leukocytes in horses experimentally infected with Anaplasma phagocytophila. 38
12204963 2002
829
Simultaneous detection of Anaplasma marginale and a new Ehrlichia species closely related to Ehrlichia chaffeensis by sequence analyses of 16S ribosomal DNA in Boophilus microplus ticks from Tibet. 38
12202567 2002
830
Comparison of serological detection methods for diagnosis of Ehrlichia canis infections in dogs. 38
12202605 2002
831
Seasonal activity patterns of Ixodes pacificus nymphs in relation to climatic conditions. 38
12243224 2002
832
[New molecular biology detection methods for tick-borne infectious agents]. 38
12224445 2002
833
Roles of p38 mitogen-activated protein kinase, NF-kappaB, and protein kinase C in proinflammatory cytokine mRNA expression by human peripheral blood leukocytes, monocytes, and neutrophils in response to Anaplasma phagocytophila. 38
12117921 2002
834
Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. 38
12149362 2002
835
Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. 38
12171295 2002
836
Detection of four Borrelia burgdorferi genospecies and first report of human granulocytic ehrlichiosis agent in Ixodes ricinus ticks collected in central Italy. 38
12211602 2002
837
Serologic and molecular detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in Korean patients. 38
12149387 2002
838
Babesiosis in humans: a treatment review. 38
12150690 2002
839
Epidemiological, clinical and laboratory distinction between human granulocytic ehrlichiosis and the initial phase of tick-borne encephalitis. 38
12422617 2002
840
Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. 38
12089287 2002
841
Infection with Anaplasma phagocytophila in cervids from Slovenia: evidence of two genotypic lineages. 38
12422618 2002
842
Diagnostics of tick-borne diseases in the endemic region of Russia. 38
12422610 2002
843
Ehrlichia ewingii infection in white-tailed deer (Odocoileus virginianus). 38
12095432 2002
844
Biology of Ixodes species ticks in relation to tick-borne zoonoses. 38
12422585 2002
845
Foci of tick-borne diseases in southwest Germany. 38
12141751 2002
846
Renal T-cell lymphoma with cerebral metastasis in a dog with chronic canine ehrlichiosis. 38
12240777 2002
847
Granulocytic ehrlichiosis in Swedish dogs and horses. 38
12141731 2002
848
Ehrlichiosis in Ixodes ricinus and wild mammals. 38
12141732 2002
849
Reinfection with Ehrlichia chaffeensis in a liver transplant recipient. 38
12032902 2002
850
HGE antibodies in sera of patients with TBE in the Czech Republic. 38
12141745 2002
851
Coinfection of Ixodes ricinus (Acari: Ixodidae) in northern Poland with the agents of Lyme borreliosis (LB) and human granulocytic ehrlichiosis (HGE). 38
12141746 2002
852
Human granulocytic ehrlichiosis in a renal allograft recipient: review of the clinical spectrum of disease in solid organ transplant patients. 38
12220247 2002
853
Serologic evidence of human granulocytic ehrlichiosis, Greece. 38
12023926 2002
854
Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent. 38
12037066 2002
855
Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. 38
11941544 2002
856
Companion animal parasitology: a clinical perspective. 38
11943231 2002
857
Seroprevalence of human granulocytic ehrlichiosis infection in Belgium. 38
12072927 2002
858
Seroprevalence of canine monocytic ehrlichiosis on Réunion. 38
12046790 2002
859
Consensus statement on ehrlichial disease of small animals from the infectious disease study group of the ACVIM. American College of Veterinary Internal Medicine. 38
12041661 2002
860
Genetic variants of Ehrlichia phagocytophila, Rhode Island and Connecticut. 38
11996680 2002
861
Novel potential reservoirs for Borrelia sp. and the agent of human granulocytic ehrlichiosis in Colorado. 38
12038153 2002
862
Outcomes of treated human granulocytic ehrlichiosis cases. 38
11971774 2002
863
Antibodies to granulocytic ehrlichiae in cattle from Connecticut. 38
11926738 2002
864
Characterization and transcriptional analysis of gene clusters for a type IV secretion machinery in human granulocytic and monocytic ehrlichiosis agents. 38
11895979 2002
865
Kinetics of CD11b/CD18 up-regulation during infection with the agent of human granulocytic ehrlichiosis in mice. 38
11896209 2002
866
Prevalence of the agent of human granulocytic ehrlichiosis in Ixodes scapularis (Acari: Ixodidae) in the coastal southeastern United States. 38
11931023 2002
867
Effects of Anaplasma phagocytophila on NADPH oxidase components in human neutrophils and HL-60 cells. 38
11854221 2002
868
Human monocytic ehrlichiosis: similar to Rocky Mountain spotted fever but different. 38
11905291 2002
869
Transcript heterogeneity of the p44 multigene family in a human granulocytic ehrlichiosis agent transmitted by ticks. 38
11854198 2002
870
Monoclonal gammopathies in the dog: a retrospective study of 18 cases (1986-1999) and literature review. 38
11908831 2002
871
Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient. 38
11927032 2002
872
Isolation and characterization of two European strains of Ehrlichia phagocytophila of equine origin. 38
11874874 2002
873
Detection of Ehrlichia canis in canine carrier blood and in individual experimentally infected ticks with a p30-based PCR assay. 38
11825969 2002
874
Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United States. 38
11814379 2002
875
Persistent Ehrlichia chaffeensis infection occurs in the absence of functional major histocompatibility complex class II genes. 38
11748204 2002
876
Infection rates of Amblyomma americanum and Dermacentor variabilis by Ehrlichia chaffeensis and Ehrlichia ewingii in southwest Missouri. 38
12653298 2002
877
Serologic evidence of ehrlichiosis among humans and wild animals in The Netherlands. 38
11915850 2002
878
Experimental infection of dusky-footed wood rats (Neotoma fuscipes) with Ehrlichia phagocytophila sensu lato. 38
11838215 2002
879
Serologic evidence of infection with granulocytic ehrlichiae in black bears in Pennsylvania. 38
11838228 2002
880
Epidemiology and impact of coinfections acquired from Ixodes ticks. 38
12804168 2002
881
Comparison of the reservoir competence of medium-sized mammals and Peromyscus leucopus for Anaplasma phagocytophilum in Connecticut. 38
12737542 2002
882
Serological and molecular evidence of human granulocytic ehrlichiosis focus in the Białowieza Primeval Forest (Puszcza Białowieska), northeastern Poland. 38
11913504 2002
883
Human granulocytic ehrlichiosis as a common cause of tick-associated fever in Southeast Sweden: report from a prospective clinical study. 38
12030391 2002
884
The prevalence of Borrelia burgdorfieri (Spirochaetales: spirochaetaceae) and the agent of human granulocytic ehrlichiosis (Rickettsiaceae: Ehrlichieae) in Ixodes scapularis (Acari:Ixodidae) collected during 1998 and 1999 from Minnesota. 38
11931260 2002
885
Treatment of human granulocytic ehrlichiosis during pregnancy and risk of perinatal transmission. 38
12578161 2002
886
The serological response of patients infected with the agent of human granulocytic ehrlichiosis. 38
11731941 2002
887
Diagnosis of human granulocytic ehrlichiosis: state of the art. 38
12804164 2002
888
Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience. 38
12372042 2002
889
Dermatitis associated with Dirofilaria (Nochtiella) repens microfilariae in dogs from central Italy. 38
12061238 2002
890
Thrombocytopenia in a mouse model of human granulocytic ehrlichiosis. 38
11709793 2001
891
First European pediatric case of human granulocytic ehrlichiosis. 38
11724894 2001
892
Host cell-specific expression of a p44 epitope by the human granulocytic ehrlichiosis agent. 38
11709787 2001
893
Population-based incidence of human granulocytic ehrlichiosis in northwestern Wisconsin, 1997-1999. 38
11709792 2001
894
Human infections tick-transmitted. 38
11677426 2001
895
Presence of immune-complexes, and absence of antinuclear antibodies, in sera of dogs naturally and experimentally infected with Ehrlichia canis. 38
11600268 2001
896
Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. 38
11568857 2001
897
Western blot analysis of sera reactive to human monocytic ehrlichiosis and human granulocytic ehrlichiosis agents. 38
11682518 2001
898
Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. 38
11760958 2001
899
Diagnosis of babesiosis using an immunoblot serologic test. 38
11687460 2001
900
Novel Ehrlichia genotype detected in dogs in South Africa. 38
11682562 2001
901
Tissue diagnosis of Ehrlichia chaffeensis in patients with fatal ehrlichiosis by use of immunohistochemistry, in situ hybridization, and polymerase chain reaction. 38
11716122 2001
902
Borrelia burgdorferi sensu lato and Ehrlichia spp. in Ixodes ticks from southern Norway. 38
11574588 2001
903
Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain. 38
11693514 2001
904
Persistent infection in Neotoma fuscipes (Muridae: Sigmodontinae) with Ehrlichia phagocytophila sensu lato. 38
11693866 2001
905
Use of a sentinel host system to study the questing behavior of Ixodes spinipalpis and its role in the transmission of Borrelia bissettii, human granulocytic ehrlichiosis, and Babesia microti. 38
11693872 2001
906
Incidence and prevalence of infection with human granulocytic ehrlichiosis agent in Germany. A prospective study in young healthy subjects. 38
11688905 2001
907
Spatial distribution of seropositivity to the causative agent of granulocytic ehrlichiosis in dogs in California. 38
11592326 2001
908
Transcriptional analysis of p30 major outer membrane multigene family of Ehrlichia canis in dogs, ticks, and cell culture at different temperatures. 38
11553557 2001
909
Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis. 38
11486290 2001
910
Life cycle of Ixodes pacificus (Acari: Ixodidae): timing of developmental processes under field and laboratory conditions. 38
11580041 2001
911
Reactivity of serum samples of dogs and horses tested by use of class-specific recombinant-based enzyme-linked immunosorbent assays for detection of granulocytic ehrlichiosis. 38
11560261 2001
912
Citrate synthase gene sequence: a new tool for phylogenetic analysis and identification of Ehrlichia. 38
11526124 2001
913
Equine monocytic Ehrlichiosis (Potomac horse fever) in horses in Uruguay and southern Brazil. 38
11580069 2001
914
Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. 38
11500432 2001
915
Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. 38
11527800 2001
916
Molecular typing of the etiologic agent of human granulocytic ehrlichiosis. 38
11526190 2001
917
Molecular identification of Borrelia valaisiana and HGE-like Ehrlichia in Ixodes ricinus ticks sampled in north-eastern Italy: first report in Veneto region. 38
11921543 2001
918
Ehrlichia-infected ticks on migrating birds. 38
11747702 2001
919
The first report of canine ehrlichiosis in Australia. 38
11599816 2001
920
Prospective assessment of the etiology of acute febrile illness after a tick bite in Slovenia. 38
11462187 2001
921
Serological survey for Ehrlichia canis in urban dogs from the major population centres of northern Australia. 38
11599818 2001
922
Molecular and antigenic comparison of Ehrlichia canis isolates from dogs, ticks, and a human in Venezuela. 38
11473993 2001
923
Equine granulocytic ehrlichiosis in the UK. 38
11504211 2001
924
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis. 38
11450674 2001
925
Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteins. 38
11427556 2001
926
Evidence of ehrlichiosis agents found in ticks (Acari: Ixodidae) collected from migratory birds. 38
11476325 2001
927
Granulocytic ehrlichiosis in a roe deer calf in Norway. 38
11504236 2001
928
Recombinant protein-44-based class-specific enzyme-linked immunosorbent assays for serologic diagnosis of human granulocytic ehrlichiosis. 38
11561804 2001
929
Recombinant major antigenic protein 2 of Ehrlichia canis: a potential diagnostic tool. 38
11427559 2001
930
Identification of Ehrlichia spp. and Borrelia burgdorferi in Ixodes ticks in the Baltic regions of Russia. 38
11376063 2001
931
Human monocytic ehrlichiosis: an emerging pathogen in transplantation. 38
11435982 2001
932
Infection of mice with the agent of human granulocytic ehrlichiosis after different routes of inoculation. 38
11372031 2001
933
Ehrlichiosis infection in a 5-year-old boy with neutropenia, anemia, thrombocytopenia, and hepatosplenomegaly. 38
11464994 2001
934
Canine granulocytic ehrlichiosis in the UK. 38
11430688 2001
935
Zoonotic infections as causes of hospitalization among febrile Bedouin patients in southern Israel. 38
11491003 2001
936
Concurrent babesiosis and ehrlichiosis in an elderly host. 38
11357805 2001
937
Characterization of a human granulocytic ehrlichiosis-like agent from Ixodes scapularis, Ontario, Canada. 38
11384537 2001
938
Proper nomenclature for the human granulocytic ehrlichiosis agent. 38
11384543 2001
939
Tickborne infections as a cause of nonspecific febrile illness in Wisconsin. 38
11317244 2001
940
Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. 38
11337387 2001
941
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. 38
11292759 2001
942
Laboratory diagnosis of ehrlichiosis and babesiosis. 38
11332670 2001
943
Assessing the association between the geographic distribution of deer ticks and seropositivity rates to various tick-transmitted disease organisms in dogs. 38
11318358 2001
944
Susceptibility of cattle to infection with Ehrlichia equi and the agent of human granulocytic ehrlichiosis. 38
11318369 2001
945
Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis. 38
11247709 2001
946
First cases of acute human granulocytic ehrlichiosis in Poland. 38
11347671 2001
947
Human granulocytic ehrlichiosis in pancreas transplant recipients. 38
11429038 2001
948
[Human granulocytic ehrlichiosis in Norway]. 38
11301703 2001
949
Efficient use of a small genome to generate antigenic diversity in tick-borne ehrlichial pathogens. 38
11274438 2001
950
Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. 38
11181154 2001
951
Antimicrobial susceptibility of Ehrlichia phagocytophila. 38
11181361 2001
952
Risk factors in habitats of the tick Ixodes ricinus influencing human exposure to Ehrlichia phagocytophila bacteria. 38
11297100 2001
953
[First detection of Ehrlichiosis detected serologically and with the polymerase chain reaction in patients with borreliosis in the Czech Republic]. 38
11347209 2001
954
[Molecular tools in the epidemiology of tick-borne bacterial diseases]. 38
11282521 2001
955
First long-term study of the seroresponse to the agent of human granulocytic ehrlichiosis among residents of a tick-endemic area of Sweden. 38
11347666 2001
956
[Ehrlichiosis infection prevalence in Spain or cross reactions]. 38
11333754 2001
957
Animal model of fatal human monocytotropic ehrlichiosis. 38
11159213 2001
958
Trimethoprim-sulfamethoxazole and fulminant ehrlichiosis. 38
11224854 2001
959
Sensitive detection of Ehrlichia chaffeensis in cell culture, blood, and tick specimens by reverse transcription-PCR. 38
11158090 2001
960
Ehrlichial proliferation and acute hepatocellular necrosis in immunocompetent mice experimentally infected with the HF strain of Ehrlichia, closely related to Ehrlichia chaffeensis. 38
11222014 2001
961
A Naval Academy midshipman with ehrlichiosis after summer field exercises in Quantico, Virginia. 38
11272720 2001
962
Tick-borne bacterial diseases emerging in Europe. 38
11298147 2001
963
Significance of serological testing for ehrlichial diseases in dogs with special emphasis on the diagnosis of canine monocytic ehrlichiosis caused by Ehrlichia canis. 38
11163693 2001
964
Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay. 38
11139221 2001
965
Acquisition dynamics of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis at the host-vector interface. 38
12680352 2001
966
Acarologic risk of exposure to emerging tick-borne bacterial pathogens in a semirural community in northern California. 38
12653148 2001
967
Prevalence of infection in ticks submitted to the human tick test kit program of the U.S. Army Center for Health Promotion and Preventive Medicine. 38
11268694 2001
968
Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses. 38
11145692 2001
969
Bloodsucking arthropods: the danger for travellers and hazard of vector travelling. 38
16888948 2001
970
Immunodiagnosis of Ehrlichia canis infection with recombinant proteins. 38
11136790 2001
971
Human granulocytic ehrlichiosis--a clinical case in Scandinavia. 38
11234985 2001
972
Interference between the agents of Lyme disease and human granulocytic ehrlichiosis in a natural reservoir host. 38
12653144 2001
973
Isolation of the etiologic agent of human granulocytic ehrlichiosis from the white-footed mouse (Peromyscus leucopus). 38
11136794 2001
974
Seroprevalence of human granulocytic ehrlichiosis in high-risk groups in Denmark. 38
11303811 2001
975
Ehrlichiosis in a moose calf in Norway. 38
11272499 2001
976
[Prevelance of the etiological agent of human ehrlichiosis (HGE) in ticks from west-north Poland]. 38
16888958 2001
977
Evaluation of a polyvalent enzyme-linked immunosorbent assay incorporating a recombinant p44 antigen for diagnosis of granulocytic ehrlichiosis in dogs and horses. 38
11197555 2001
978
[Incidence and seroprevalence of canine ehrlichiosis in the Medjez El Bab region (northwestern Tunisia during 1994, 1995 and 1996]. 38
14658238 2001
979
New uses of older antibiotics. 38
11190348 2001
980
Coinfection with three Ehrlichia species in dogs from Thailand and Venezuela with emphasis on consideration of 16S ribosomal DNA secondary structure. 38
11136754 2001
981
Detection of Ehrlichia chaffeensis DNA in Amblyomma americanum ticks in Connecticut and Rhode Island. 38
11101616 2000
982
Human granulocytic ehrlichiosis agent inhibits superoxide anion generation by human neutrophils. 38
11083784 2000
983
Ehrlichial diseases. 38
11219345 2000
984
Myopericarditis associated with central European tick-borne encephalitis. 38
11079201 2000
985
Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman. 38
11073767 2000
986
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis suppresses IL-2 and IFN gamma production and promotes an IL-4 response in C3H/HeJ mice. 38
11116438 2000
987
Panic attacks may reveal previously unsuspected chronic disseminated lyme disease. 38